Datasets:
sovai
/
lobbying_data

Dataset card Data Studio Files
xet
Community
ticker
stringlengths
1
10
date
timestamp[ns]
client
stringlengths
1
80
client_description
stringlengths
2
114
⌀
spend
float64
0
25.9M
transaction_type
stringclasses
7 values
filing_type
stringclasses
7 values
lobby_description
listlengths
0
34
issue_codes
listlengths
1
34
⌀
government_entity_details
listlengths
1
725
⌀
quarter
stringclasses
66 values
effective_date
stringlengths
10
10
termination_date
stringlengths
10
10
⌀
client_state
stringclasses
56 values
client_country
stringclasses
40 values
client_id
int64
12
10M
government_lobby
float64
0
1
⌀
performing_own_lobbying
float64
0
1
⌀
registrant_dt_updated
stringlengths
32
32
registrant_name
stringlengths
3
99
registrant_address
stringlengths
32
87
registrant_id
int64
33
401M
registrant_description
stringlengths
2
103
⌀
registrant_contact_name
stringlengths
0
34
registrant_house_registrant_id
float64
12.7k
401M
⌀
registrant_contact_telephone
stringlengths
0
16
lobbyist_full_names
listlengths
1
272
⌀
lobbyist_ids
listlengths
1
272
⌀
previous_goverment_positions
listlengths
1
272
⌀
lobbyist_new_statuses
listlengths
1
272
⌀
client_url
stringlengths
44
45
registrant_url
stringlengths
45
52
filing_url
stringlengths
88
88
filing_id
stringlengths
36
36
unique_id
stringlengths
46
53
match
stringlengths
1
80
date_time
timestamp[ns]
YNCHF
2017-10-20T00:00:00
astellas pharma us, inc.
pharmaceutical company
50,000
lobbying_income
service_provided
[ "- Issues related to Medicare Part B (HOPPS) and Part D \n- Provisions related to repeal of the Independent Payment Advisory Board (IPAB)", "- FDA Reauthorization Act (H.R. 2430/S. 934)\n- Issues related to the Bayh-Dole Act (Pub. L. 96-517)\n- Issues related to drug pricing and value\n- Issues related to the importation of prescription medicines" ]
[ "MMM - Medicare/Medicaid", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2017-Q3
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY" ]
[ 56477, 64580, 64580, 56477 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/6d0a6398-7859-4ff9-ac11-cef59e701552/print/
6d0a6398-7859-4ff9-ac11-cef59e701552
6d0a6398-7859-4ff9-ac11-cef59e701552_400762305_195037
astellas pharma us, inc.
2017-10-20T18:27:07
YNCHF
2017-11-13T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
modify_service
[ "Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152). Issues related to CMS Outpatient Prospective Payment System (OPPS) rule. H.R. 1178, Ensuring Equal Access to Treatments Act of 2015. S.1466, Ensuring Equal Access to Treatments Act of 2015. Issues related to march-in rights under Bayh-Dole Act (Pub. L. 96-517)." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2016-Q3
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SEAN RICHARDSON" ]
[ 47178, 26450, 6542 ]
[ null, null, null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/d553e3b7-9fa6-4371-b296-3c5805233c39/print/
d553e3b7-9fa6-4371-b296-3c5805233c39
d553e3b7-9fa6-4371-b296-3c5805233c39_20744_127151
astellas pharma us, inc.
2017-11-13T17:49:10
YNCHF
2017-12-15T00:00:00
astellas pharma us, inc.
null
570,000
a
modify_service
[ "Proposed Regulations under IRC Sec. 385 regarding their impact on the ability of U.S. subsidiaries to invest and grow in the United States and the competitiveness of the United States as a location for foreign direct investment; comprehensive tax reform.", "Issues related to oral chemotherapy in The Cancer Drug Coverage Parity Act of 2017 (H.R.1409); Value of Prescription Drugs, Senate & House; Issues related to march-in rights under Bayh-Dole Act (Pub. L. 96-517); Issues related to the Prescription Drug User Fee Act (PDUFA) reauthorization; Issues related to importation (no specific bills).", "Issues related to the Medicare hospital outpatient issues; Medicare Part D policy issues.\nS. 251: Protecting Medicare from Executive Action Act of 2017 - Provisions related to repeal of the Independent Payment Advisory Board (IPAB)\nS. 260: Protecting Seniors' Access to Medicare Act of 2017 - Provisions related to repeal of the IPAB\nH.R. 849: Protecting Seniors' Access to Medicare Act of 2017 - Provisions related to repeal of the IPAB\nH.J.Res. 51 - Approving the discontinuation of the process for consideration and automatic implementation of the annual proposal of the Independent Medicare Advisory Board under section 1899A of the Social Security Act - Provisions related to the IPAB repeal\nS.J.Res. 16 - A joint resolution approving the discontinuation of the process for consideration and automatic implementation of the annual proposal of the Independent Medicare Advisory Board under section 1899A of the Social Security Act - Provisions related to the IPAB repeal" ]
[ "TAX - Taxation/Internal Revenue Code", "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2017-Q2
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MARY LACEY REUTHER", "MELISSA WIER BANASHAK", "SARAH CHRISTINE D'ORSIE", "MARY LACEY REUTHER", "MELISSA WIER BANASHAK", "SARAH CHRISTINE D'ORSIE", "MARY LACEY REUTHER", "MELISSA WIER BANASHAK", "SARAH CHRISTINE D'ORSIE" ]
[ 54800, 59772, 64567, 54800, 59772, 64567, 54800, 59772, 64567 ]
[ null, null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/11fca9d8-868d-48bb-9ba7-a2ea3050c9ac/print/
11fca9d8-868d-48bb-9ba7-a2ea3050c9ac
11fca9d8-868d-48bb-9ba7-a2ea3050c9ac_40032268_188248
astellas pharma us, inc.
2017-12-15T00:20:22
YNCHF
2018-01-01T00:00:00
astellas pharma us
Pharmaceutical company
75,000
lobbying_income
modify_service
[ "REIMBURSEMENT ISSUES", "PHARMACEUTICAL AND LIFE SCIENCES ISSUES" ]
[ "MMM - Medicare/Medicaid", "HCR - Health Issues" ]
[ "136 - Centers For Medicare and Medicaid Services (CMS)", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "136 - Centers For Medicare and Medicaid Services (CMS)", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2009-Q1
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "AARON COHEN (POLICY ADVISOR, SEN. ENSIGN & BRYAN)", "JODIE LOCKHART", "JENNIFER VESEY ROSSMAN (POLICY ADVISOR, SEN. RICK SANTORUM)", "JEFFREY J KIMBELL", "AARON COHEN (POLICY ADVISOR, SEN. ENSIGN & BRYAN)", "JODIE LOCKHART", "JENNIFER VESEY ROSSMAN (POLICY ADVISOR, SEN. RICK SANTORUM)" ]
[ 42442, 35755, 51434, 39999, 42442, 35755, 51434, 39999 ]
[ null, "POLICY ADVISOR, SEN. ENSIGN & BRYAN", null, "POLICY ADVISOR, SEN. RICK SANTORUM", null, "POLICY ADVISOR, SEN. ENSIGN & BRYAN", null, "POLICY ADVISOR, SEN. RICK SANTORUM" ]
[ false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/744ab56c-688a-46d0-9424-5368692e0fb8/print/
744ab56c-688a-46d0-9424-5368692e0fb8
744ab56c-688a-46d0-9424-5368692e0fb8_46038_153900
astellas pharma us
null
YNCHF
2018-01-01T00:00:00
astellas pharma us
Pharmaceutical company
40,000
lobbying_income
service_provided
[ "PHARMACEUTICAL AND LIFE SCIENCE ISSUES", "REIMBURSEMENT ISSUES" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "136 - Centers For Medicare and Medicaid Services (CMS)", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "136 - Centers For Medicare and Medicaid Services (CMS)", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2009-Q4
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "JENNIFER VESEY ROSSMAN (POLICY ADVISOR, SEN. RICK SANTORUM)", "JEFFREY J KIMBELL", "JODIE LOCKHART", "JENNIFER VESEY ROSSMAN (POLICY ADVISOR, SEN. RICK SANTORUM)" ]
[ 42442, 51434, 39999, 42442, 51434, 39999 ]
[ null, null, "POLICY ADVISOR, SEN. RICK SANTORUM", null, null, "POLICY ADVISOR, SEN. RICK SANTORUM" ]
[ false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/883f0264-3369-4cf8-82f8-3e4b861ca463/print/
883f0264-3369-4cf8-82f8-3e4b861ca463
883f0264-3369-4cf8-82f8-3e4b861ca463_46038_153900
astellas pharma us
null
YNCHF
2018-01-01T00:00:00
astellas pharma us
Pharmaceutical company
40,000
lobbying_income
service_provided
[ "GENERAL HEALTH CARE ISSUES, ISSUES RELATED TO FDA, PHARMACEUTICALS" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2016-Q4
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "KENNETH LEE HODGE", "JEFFREY J KIMBELL", "JODIE LOCKHART", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)" ]
[ 139878, 42442, 51434, 60159 ]
[ null, null, null, "Legislative Director, Rep. Marsha Blackburn" ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/cecd4853-524d-45b2-a32c-26cadc8f53d6/print/
cecd4853-524d-45b2-a32c-26cadc8f53d6
cecd4853-524d-45b2-a32c-26cadc8f53d6_46038_153900
astellas pharma us
null
YNCHF
2018-01-12T00:00:00
astellas pharma us
Pharmaceutical company
40,000
lobbying_income
service_provided
[ "S.1519 - National Defense Authorization Act for Fiscal Year 2018", "Tax Reform", "Issues related to pharmaceutical pricing and NIH March In Rights" ]
[ "DEF - Defense", "TAX - Taxation/Internal Revenue Code", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2017-Q4
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)", "JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)", "JEFFREY J KIMBELL", "JODIE LOCKHART", "JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)", "JEFFREY J KIMBELL", "JODIE LOCKHART", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)", "JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)" ]
[ 42442, 51434, 60159, 53650, 42442, 51434, 53650, 60159, 42442, 51434, 60159, 53650 ]
[ null, null, "Legislative Director, Rep. Marsha Blackburn", "Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President", null, null, "Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President", "Legislative Director, Rep. Marsha Blackburn", null, null, "Legislative Director, Rep. Marsha Blackburn", "Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President" ]
[ false, false, false, false, false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/6c87664b-6c58-48e8-ac74-f64fbcacfb2b/print/
6c87664b-6c58-48e8-ac74-f64fbcacfb2b
6c87664b-6c58-48e8-ac74-f64fbcacfb2b_46038_153900
astellas pharma us
2018-01-12T18:28:49
YNCHF
2018-01-19T00:00:00
astellas pharma us, inc.
Pharmaceuticals
50,000
lobbying_income
service_provided
[ "Issues related to P.L. 96-517, the Bayh-Dole Act; issues related to drug pricing; S. 1519 and H.R. 2810, National Defense Authorization Act; Labor, HHS and Education FY18 Appropriations Bill" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2017-Q4
2014-11-01
null
IL
US
1,004,265
0
null
2024-01-30T13:11:27.932595-05:00
PORTERFIELD, FETTIG & SEARS, LLC
400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US
305,054
government affairs
DAWN SEARS
38,091
+1 202-715-0845
[ "JEREMY RABINOVITZ" ]
[ 61187 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/181397/
https://lda.senate.gov/api/v1/registrants/305054/
https://lda.senate.gov/filings/public/filing/38ff5371-3304-4090-b20e-c1eafef01c6f/print/
38ff5371-3304-4090-b20e-c1eafef01c6f
38ff5371-3304-4090-b20e-c1eafef01c6f_305054_181397
astellas pharma us, inc.
2018-01-19T19:13:35
YNCHF
2018-01-22T00:00:00
astellas pharma us, inc.
pharmaceutical company
50,000
lobbying_income
service_provided
[ "- Issues related to Medicare Part B (HOPPS) and Part D \n- Provisions related to repeal of the Independent Payment Advisory Board (IPAB)", "- Issues related to the Bayh-Dole Act (Pub. L. 96-517)\n- Issues related to drug pricing and value\n- Issues related to the importation of prescription medicines" ]
[ "MMM - Medicare/Medicaid", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2017-Q4
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY" ]
[ 64580, 56477, 64580, 56477 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/ff2095e0-04ca-468f-940e-7d0acc0841d3/print/
ff2095e0-04ca-468f-940e-7d0acc0841d3
ff2095e0-04ca-468f-940e-7d0acc0841d3_400762305_195037
astellas pharma us, inc.
2018-01-22T15:30:54
YNCHF
2018-01-22T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "issues relating to drug pricing, march-in rights under Bayh-Dole Act P.L. 96-517 and transparency. S.1519, the National Defense Authorization Act for 2018, Section 892, Rights in technical data related to medical research. HR 2819 - National Defense Authorization Act (FY18), Amendment 342, Rep. Doggett" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2017-Q4
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SEAN RICHARDSON" ]
[ 47178, 26450, 6542 ]
[ null, null, null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/1364bd26-6524-4372-804e-865690dd820e/print/
1364bd26-6524-4372-804e-865690dd820e
1364bd26-6524-4372-804e-865690dd820e_20744_127151
astellas pharma us, inc.
2018-01-22T17:00:37
YNCHF
2018-01-22T00:00:00
astellas pharma us, inc.
null
490,000
a
service_provided
[ "Proposed Regulations under IRC Sec. 385 regarding their impact on the ability of U.S. subsidiaries to invest and grow in the United States and the competitiveness of the United States as a location for foreign direct investment; comprehensive tax reform.", "Issues related to oral chemotherapy in The Cancer Drug Coverage Parity Act of 2017 (H.R.1409); Value of Prescription Drugs, Senate & House; Issues related to march-in rights under Bayh-Dole Act (Pub. L. 96-517); Issues related to importation (no specific bills).", "Issues related to the Medicare hospital outpatient issues; Medicare Part D policy issues.\nS. 251: Protecting Medicare from Executive Action Act of 2017 - Provisions related to repeal of the Independent Payment Advisory Board (IPAB)\nS. 260: Protecting Seniors' Access to Medicare Act of 2017 - Provisions related to repeal of the IPAB\nH.R. 849: Protecting Seniors' Access to Medicare Act of 2017 - Provisions related to repeal of the IPAB\nH.J.Res. 51 - Approving the discontinuation of the process for consideration and automatic implementation of the annual proposal of the Independent Medicare Advisory Board under section 1899A of the Social Security Act - Provisions related to the IPAB repeal\nS.J.Res. 16 - A joint resolution approving the discontinuation of the process for consideration and automatic implementation of the annual proposal of the Independent Medicare Advisory Board under section 1899A of the Social Security Act - Provisions related to the IPAB repeal" ]
[ "TAX - Taxation/Internal Revenue Code", "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2017-Q4
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MARY LACEY REUTHER", "SARAH CHRISTINE D'ORSIE", "MARY LACEY REUTHER", "SARAH CHRISTINE D'ORSIE", "MARY LACEY REUTHER", "SARAH CHRISTINE D'ORSIE" ]
[ 54800, 64567, 54800, 64567, 54800, 64567 ]
[ null, null, null, null, null, null ]
[ false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/53058ccd-0182-4bce-a00b-ee44019503ef/print/
53058ccd-0182-4bce-a00b-ee44019503ef
53058ccd-0182-4bce-a00b-ee44019503ef_40032268_188248
astellas pharma us, inc.
2018-01-22T20:45:03
YNCHF
2018-04-06T00:00:00
astellas pharma us
Pharmaceutical company
40,000
lobbying_income
service_provided
[ "National Defense Authorization Act for Fiscal Year 2019", "Issues related to pharmaceutical pricing and NIH March In Rights", "Issues related to pharmaceutical pricing" ]
[ "DEF - Defense", "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2018-Q1
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)", "JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)", "JEFFREY J KIMBELL", "JODIE LOCKHART", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)", "JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)", "JEFFREY J KIMBELL", "JODIE LOCKHART", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)" ]
[ 42442, 51434, 60159, 53650, 42442, 51434, 60159, 53650, 42442, 51434, 60159 ]
[ null, null, "Legislative Director, Rep. Marsha Blackburn", "Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President", null, null, "Legislative Director, Rep. Marsha Blackburn", "Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President", null, null, "Legislative Director, Rep. Marsha Blackburn" ]
[ false, false, false, false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/6ab31622-7c68-4a5b-9c6b-711c8ed7ff8d/print/
6ab31622-7c68-4a5b-9c6b-711c8ed7ff8d
6ab31622-7c68-4a5b-9c6b-711c8ed7ff8d_46038_153900
astellas pharma us
2018-04-06T17:00:35
YNCHF
2018-04-19T00:00:00
astellas pharma us, inc.
Pharmaceuticals
0
lobbying_income
service_provided
[ "S. 2482; S.2039; H.R. 4170", "Issues related to P.L. 96-517, the Bayh-Dole Act; issues related to drug pricing" ]
[ "GOV - Government Issues", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2018-Q1
2014-11-01
null
IL
US
1,004,265
0
null
2024-01-30T13:11:27.932595-05:00
PORTERFIELD, FETTIG & SEARS, LLC
400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US
305,054
government affairs
DAWN SEARS
38,091
+1 202-715-0845
[ "JEREMY RABINOVITZ", "JEREMY RABINOVITZ" ]
[ 61187, 61187 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/181397/
https://lda.senate.gov/api/v1/registrants/305054/
https://lda.senate.gov/filings/public/filing/dfdfec80-12ee-4142-bb9a-174e3cf8c612/print/
dfdfec80-12ee-4142-bb9a-174e3cf8c612
dfdfec80-12ee-4142-bb9a-174e3cf8c612_305054_181397
astellas pharma us, inc.
2018-04-19T18:41:48
YNCHF
2018-04-20T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "issues relating to drug pricing, march-in rights under Bayh-Dole Act P.L. 96-517 and transparency. S.1519, the National Defense Authorization Act for 2018, Section 892, Rights in technical data related to medical research. HR 2819 - National Defense Authorization Act (FY18), Amendment 342, Rep. Doggett", "S. 2482 - Foreign Agents Registration Amendment Act of 2018; S. 2039 - Disclosing Foreign Influence Act; HR 4170 - Disclosing Foreign Influence Act" ]
[ "HCR - Health Issues", "FOR - Foreign Relations" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2018-Q1
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SEAN RICHARDSON", "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SEAN RICHARDSON" ]
[ 47178, 26450, 6542, 47178, 26450, 6542 ]
[ null, null, null, null, null, null ]
[ false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/19264120-31e4-4603-b1e4-79dd5180b210/print/
19264120-31e4-4603-b1e4-79dd5180b210
19264120-31e4-4603-b1e4-79dd5180b210_20744_127151
astellas pharma us, inc.
2018-04-20T16:22:22
YNCHF
2018-04-20T00:00:00
astellas pharma us, inc.
null
780,000
a
service_provided
[ "Value of Prescription Drugs, Senate & House; Issues related to march-in rights under Bayh-Dole Act (Pub. L. 96-517); Issues related to importation (no specific bills).", "Issues related to Medicare Part D policy (no specific bills).", "H.R. 4170 Disclosing Foreign Influence Act; S. 2482 Foreign Agents Registration Amendments Act", "Proposed Regulations under IRC Sec. 385 regarding their impact on the ability of U.S. subsidiaries to invest and grow in the United States and the competitiveness of the United States as a location for foreign direct investment; comprehensive tax reform." ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid", "LAW - Law Enforcement/Crime/Criminal Justice", "TAX - Taxation/Internal Revenue Code" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2018-Q1
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MARY LACEY REUTHER", "SARAH CHRISTINE D'ORSIE", "VALARIE MOLAISON (Congressional Science Fellow for Sen. Jon Tester (MT); Health Legislative Assistant for Sen. Sherrod Brown (OH))", "MARY LACEY REUTHER", "SARAH CHRISTINE D'ORSIE", "VALARIE MOLAISON (Congressional Science Fellow for Sen. Jon Tester (MT); Health Legislative Assistant for Sen. Sherrod Brown (OH))", "MARY LACEY REUTHER", "SARAH CHRISTINE D'ORSIE", "VALARIE MOLAISON (Congressional Science Fellow for Sen. Jon Tester (MT); Health Legislative Assistant for Sen. Sherrod Brown (OH))", "MARY LACEY REUTHER", "SARAH CHRISTINE D'ORSIE", "VALARIE MOLAISON (Congressional Science Fellow for Sen. Jon Tester (MT); Health Legislative Assistant for Sen. Sherrod Brown (OH))" ]
[ 54800, 64567, 68274, 54800, 64567, 68274, 54800, 64567, 68274, 54800, 64567, 68274 ]
[ null, null, "Congressional Science Fellow for Sen. Jon Tester (MT); Health Legislative Assistant for Sen. Sherrod Brown (OH)", null, null, "Congressional Science Fellow for Sen. Jon Tester (MT); Health Legislative Assistant for Sen. Sherrod Brown (OH)", null, null, "Congressional Science Fellow for Sen. Jon Tester (MT); Health Legislative Assistant for Sen. Sherrod Brown (OH)", null, null, "Congressional Science Fellow for Sen. Jon Tester (MT); Health Legislative Assistant for Sen. Sherrod Brown (OH)" ]
[ false, false, true, false, false, true, false, false, true, false, false, true ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/453ae288-9660-402e-86d7-d7c5cd0cedb4/print/
453ae288-9660-402e-86d7-d7c5cd0cedb4
453ae288-9660-402e-86d7-d7c5cd0cedb4_40032268_188248
astellas pharma us, inc.
2018-04-20T20:09:40
YNCHF
2018-04-20T00:00:00
astellas pharma us, inc.
pharmaceutical company
50,000
lobbying_income
service_provided
[ "- Issues related to the Bayh-Dole Act (Pub. L. 96-517)\n- Issues related to drug pricing and value, generally\n- Issues related to the importation of prescription medicines, generally", "- Issues related to lobbying disclosure for US affiliates in the Disclosing Foreign Influence Act (H.R.4170/S. 2039) and Foreign Agents Registration Amendments Act (S. 2482)", "- Issues related to Medicare Part B (HOPPS), generally\n- Issues related to Medicare Part D; the Bipartisan Budget Act (H.R. 1892); and the Consolidated Appropriations Act (H.R. 1625)\n- Issues related to the repeal of the Independent Payment Advisory Board (IPAB); Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849/S. 260); Protecting Medicare from Executive Action Act of 2017 (S. 251)" ]
[ "HCR - Health Issues", "FOR - Foreign Relations", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2018-Q1
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "LYDIA STRUNK (Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner))", "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "LYDIA STRUNK (Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner))", "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "LYDIA STRUNK (Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner))" ]
[ 64580, 56477, 66328, 56477, 64580, 66328, 64580, 56477, 66328 ]
[ null, null, "Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner)", null, null, "Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner)", null, null, "Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner)" ]
[ false, false, true, false, false, true, false, false, true ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/cbd3aae6-7f91-4868-9cf5-9dd07882078b/print/
cbd3aae6-7f91-4868-9cf5-9dd07882078b
cbd3aae6-7f91-4868-9cf5-9dd07882078b_400762305_195037
astellas pharma us, inc.
2018-04-20T20:12:25
YNCHF
2018-05-03T00:00:00
astellas pharma us, inc.
Pharmaceuticals
50,000
lobbying_income
modify_service
[ "Issues related to P.L. 96-517, the Bayh-Dole Act; issues related to drug pricing", "S. 2482, Foreign Agents Registration Amendments Act of 2018; S.2039, Disclosing Foreign Influence Act; H.R. 4170, Disclosing Foreign Influence Act." ]
[ "HCR - Health Issues", "GOV - Government Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2018-Q1
2014-11-01
null
IL
US
1,004,265
0
null
2024-01-30T13:11:27.932595-05:00
PORTERFIELD, FETTIG & SEARS, LLC
400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US
305,054
government affairs
DAWN SEARS
38,091
+1 202-715-0845
[ "JEREMY RABINOVITZ", "JEREMY RABINOVITZ" ]
[ 61187, 61187 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/181397/
https://lda.senate.gov/api/v1/registrants/305054/
https://lda.senate.gov/filings/public/filing/bca8a73e-3e64-4fc5-9cbe-39d5fdb83b75/print/
bca8a73e-3e64-4fc5-9cbe-39d5fdb83b75
bca8a73e-3e64-4fc5-9cbe-39d5fdb83b75_305054_181397
astellas pharma us, inc.
2018-05-03T19:13:37
YNCHF
2018-05-17T00:00:00
astellas pharma us, inc.
null
574,908
a
service_provided
[ "Tariff duty suspension", "Issues related to the implementation of Section 501(c) of the 2005 Deficit Reduction Act; Issues related to hospital readmissions/bundling and home infusion therapy coverage (HR 574/S 254); The Comprehensive Immunosuppressive Drug Coverage for Transplant Patients Act (HR 1458/S 565); Issues related to Medicare Hospital Outpatient Prospective Payment System (HR 4371); Issues related to Medicare Part D dual eligibles rebate (see applicable bills on next page) (continued from previous page) - (America's Affordable Health Choices Act of 2009 (HR 3200); Service Member's Home Owenership Tax Act of 2009 (HR 3590); America's Healthy Future Act of 2009 (S 1796); Affordable Health Choices Act (S 1679); Affordable Health Care for America Act (HR 3962))", "The Data Accountability and Trust Act (HR 2221)", "Issues pertaining to antimicrobial resistance (HR 2400); Issues pertaining to community and healthcare associated infections; Issues pertaining to medical isotopes (American Medical Isotopes Production Act of 2009 (HR 3276)); Issues related to 340B program, drug importation and follow-on biologics (America's Affordable Health Choices Act of 2009 (HR 3200); Service Member's Home Ownership Tax Act of 2009 (HR 3590); America's Healthy Future Act of 2009 (S 1796); (continued next page) (continued from previous page) - Affordable Health Choices Act (S. 1679); Affordable Health Care for America Act (HR 3962))." ]
[ "TRD - Trade (domestic/foreign)", "MMM - Medicare/Medicaid", "TEC - Telecommunications", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2009-Q4
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MICHAEL RUGGIERO", "SAMANTHA VENTIMIGLIA", "MICHAEL RUGGIERO", "SAMANTHA VENTIMIGLIA", "MICHAEL RUGGIERO", "SAMANTHA VENTIMIGLIA", "MICHAEL RUGGIERO", "SAMANTHA VENTIMIGLIA" ]
[ 40398, 40403, 40398, 40403, 40398, 40403, 40398, 40403 ]
[ null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/bb14b071-79df-48d8-8248-87b0ed3d4c2b/print/
bb14b071-79df-48d8-8248-87b0ed3d4c2b
bb14b071-79df-48d8-8248-87b0ed3d4c2b_40032268_188248
astellas pharma us, inc.
null
YNCHF
2018-05-17T00:00:00
astellas pharma us, inc.
null
740,000
a
service_provided
[ "Issues related to various patent reform bills (H.R.9, S.632, S.1137).", "Proposed Regulations under IRC Sec. 385 regarding their impact on the ability of U.S. subsidiaries to invest and grow in the United States and the competitiveness of the United States as a location for foreign direct investment.", "Issues related to the implementation of healthcare reform (P.L.111-148, P.L.111-152); Issues related to oral chemotherapy in The Cancer Drug Coverage Parity Act (S.1566, H.R.2739); The 21st Century Cures Act (H.R.6); Food and Drug Administration Safety and Innovation Act (FDASIA) policy issues; Value of Prescription Drugs, Senate & House; Issues related to march-in rights under Bayh-Dole Act (Pub. L. 96-517).", "Issues related to the implementation of health care reform (P.L.111-148, P.L.111-152); Issues related to the Medicare hospital outpatient issues (H.R.1178, S.1466); Developing an Innovative Strategy for Antimicrobial Resistance Microorganisms Act of 2015 (DISARM) (H.R.512); Medicare Program; Part B Drug Payment Model, Proposed rule, CMS-1670-P (March 11, 2016) - Provisions related to the Medicare Part B Drug Payment Model; H.R. 5122: To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models - Suspending the Part B Drug Payment Model; Medicare Part D rebates policy issues." ]
[ "CPT - Copyright/Patent/Trademark", "TAX - Taxation/Internal Revenue Code", "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2016-Q4
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MARY LACEY REUTHER", "MELISSA WIER BANASHAK", "SARAH CHRISTINE D'ORSIE (Professional Staff for Rep. Tom Davis; Clerk for Rep. Todd Platts; Intern for Sen. Rick Santorum)", "MARY LACEY REUTHER", "MELISSA WIER BANASHAK", "SARAH CHRISTINE D'ORSIE", "MARY LACEY REUTHER", "MELISSA WIER BANASHAK", "SARAH CHRISTINE D'ORSIE", "MARY LACEY REUTHER", "MELISSA WIER BANASHAK", "SARAH CHRISTINE D'ORSIE" ]
[ 54800, 59772, 64567, 54800, 59772, 64567, 54800, 59772, 64567, 54800, 59772, 64567 ]
[ null, null, "Professional Staff for Rep. Tom Davis; Clerk for Rep. Todd Platts; Intern for Sen. Rick Santorum", null, null, null, null, null, null, null, null, null ]
[ false, false, true, false, false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/482b9f27-ecb6-4314-a58e-266116a7677a/print/
482b9f27-ecb6-4314-a58e-266116a7677a
482b9f27-ecb6-4314-a58e-266116a7677a_40032268_188248
astellas pharma us, inc.
null
YNCHF
2018-07-09T00:00:00
astellas pharma us
Pharmaceutical company
40,000
lobbying_income
service_provided
[ "Issues related to pharmaceutical pricing and NIH March In Rights", "Issues related to pharmaceutical pricing", "Disclosing Foreign Influence Act", "National Defense Authorization Act for Fiscal Year 2019" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid", "LAW - Law Enforcement/Crime/Criminal Justice", "DEF - Defense" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2018-Q2
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)", "JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)", "JEFFREY J KIMBELL", "JODIE LOCKHART", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)", "JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)", "JEFFREY J KIMBELL", "JODIE LOCKHART", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)", "JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)", "JEFFREY J KIMBELL", "JODIE LOCKHART", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)", "JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)" ]
[ 42442, 51434, 60159, 53650, 42442, 51434, 60159, 53650, 42442, 51434, 60159, 53650, 42442, 51434, 60159, 53650 ]
[ null, null, "Legislative Director, Rep. Marsha Blackburn", "Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President", null, null, "Legislative Director, Rep. Marsha Blackburn", "Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President", null, null, "Legislative Director, Rep. Marsha Blackburn", "Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President", null, null, "Legislative Director, Rep. Marsha Blackburn", "Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President" ]
[ false, false, false, false, false, false, false, false, false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/9bf4faa8-4e68-4e78-bd1a-79aef5d216c8/print/
9bf4faa8-4e68-4e78-bd1a-79aef5d216c8
9bf4faa8-4e68-4e78-bd1a-79aef5d216c8_46038_153900
astellas pharma us
2018-07-09T21:37:55
YNCHF
2018-07-10T00:00:00
astellas pharma us
Pharmaceutical company
40,000
lobbying_income
modify_service
[ "General health care issues, issues related to FDA, pharmaceuticals" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2017-Q1
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)", "KENNETH LEE HODGE" ]
[ 42442, 51434, 60159, 139878 ]
[ null, null, "Legislative Director, Rep. Marsha Blackburn", null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/e2bee2a2-67b1-43eb-a3af-6b336aafdd89/print/
e2bee2a2-67b1-43eb-a3af-6b336aafdd89
e2bee2a2-67b1-43eb-a3af-6b336aafdd89_46038_153900
astellas pharma us
2018-07-10T15:03:11
YNCHF
2018-07-19T00:00:00
astellas pharma us, inc.
Pharmaceuticals
50,000
lobbying_income
service_provided
[ "Issues related to P.L. 96-517, the Bayh-Dole Act; issues related to drug pricing; issues related to Medicare Part D Coverage.", "S. 2482, Foreign Agents Registration Amendments Act of 2018; S.2039, Disclosing Foreign Influence Act; H.R. 4170, Disclosing Foreign Influence Act." ]
[ "HCR - Health Issues", "GOV - Government Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2018-Q2
2014-11-01
null
IL
US
1,004,265
0
null
2024-01-30T13:11:27.932595-05:00
PORTERFIELD, FETTIG & SEARS, LLC
400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US
305,054
government affairs
DAWN SEARS
38,091
+1 202-715-0845
[ "JEREMY RABINOVITZ", "JEREMY RABINOVITZ" ]
[ 61187, 61187 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/181397/
https://lda.senate.gov/api/v1/registrants/305054/
https://lda.senate.gov/filings/public/filing/92aff7ad-48cc-46e9-872c-183c9b632538/print/
92aff7ad-48cc-46e9-872c-183c9b632538
92aff7ad-48cc-46e9-872c-183c9b632538_305054_181397
astellas pharma us, inc.
2018-07-19T20:17:38
YNCHF
2018-07-20T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "issues relating to drug pricing, march-in rights under Bayh-Dole Act P.L. 96-517 and transparency. S.1519, the National Defense Authorization Act for 2018, Section 892, Rights in technical data related to medical research. HR 2819 - National Defense Authorization Act (FY18), Amendment 342, Rep. Doggett", "S. 2482 - Foreign Agents Registration Amendment Act of 2018; S. 2039 - Disclosing Foreign Influence Act; HR 4170 - Disclosing Foreign Influence Act" ]
[ "HCR - Health Issues", "FOR - Foreign Relations" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2018-Q2
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SEAN RICHARDSON", "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SEAN RICHARDSON" ]
[ 47178, 26450, 6542, 47178, 26450, 6542 ]
[ null, null, null, null, null, null ]
[ false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/f7fc8ca2-fdb5-42e8-883e-a78886bda22e/print/
f7fc8ca2-fdb5-42e8-883e-a78886bda22e
f7fc8ca2-fdb5-42e8-883e-a78886bda22e_20744_127151
astellas pharma us, inc.
2018-07-20T16:53:16
YNCHF
2018-07-20T00:00:00
astellas pharma us, inc.
pharmaceutical company
50,000
lobbying_income
service_provided
[ "- Issues related to the Bayh-Dole Act (Pub. L. 96-517)\n- Issues related to drug pricing and value, generally\n- Issues related to the importation of prescription medicines, generally", "- Issues related to lobbying disclosure for US affiliates in the Disclosing Foreign Influence Act (H.R.4170/S. 2039) and Foreign Agents Registration Amendments Act (S. 2482)", "- Issues related to Medicare Part B (HOPPS), generally\n- Issues related to Medicare Part D; the Bipartisan Budget Act (H.R. 1892); and the Consolidated Appropriations Act (H.R. 1625)\n- Issues related to the repeal of the Independent Payment Advisory Board (IPAB); Protecting Seniors' Access to Medicare Act of 2017 (H.R. 849/S. 260); Protecting Medicare from Executive Action Act of 2017 (S. 251)" ]
[ "HCR - Health Issues", "FOR - Foreign Relations", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2018-Q2
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "LYDIA STRUNK (Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner))", "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "LYDIA STRUNK (Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner))", "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "LYDIA STRUNK (Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner))" ]
[ 64580, 56477, 66328, 56477, 64580, 66328, 64580, 56477, 66328 ]
[ null, null, "Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner)", null, null, "Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner)", null, null, "Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner)" ]
[ false, false, true, false, false, true, false, false, true ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/d9cb71e1-2819-4db4-ba5d-4516a0cb7305/print/
d9cb71e1-2819-4db4-ba5d-4516a0cb7305
d9cb71e1-2819-4db4-ba5d-4516a0cb7305_400762305_195037
astellas pharma us, inc.
2018-07-20T19:52:58
YNCHF
2018-07-20T00:00:00
astellas pharma us, inc.
null
490,000
a
service_provided
[ "House and Senate Appropriations for Fiscal Year ending Sept 30. 2018.", "Value of Prescription Drugs, Senate & House; Issues related to march-in rights under Bayh-Dole Act (Pub. L. 96-517); PAHPA (S. 2852/H.R. 6378) Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; REVAMP (H.R. 6294) Re-Valuing Anti-Microbial Products Act of 2018.", "Issues related to Medicare Part D policy (no specific bills).", "H.R. 4170 Disclosing Foreign Influence Act; S. 2482 Foreign Agents Registration Amendments Act" ]
[ "BUD - Budget/Appropriations", "HCR - Health Issues", "MMM - Medicare/Medicaid", "LAW - Law Enforcement/Crime/Criminal Justice" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2018-Q2
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MARY LACEY REUTHER", "VALARIE MOLAISON", "JOSEPH DEVANEY", "MARY LACEY REUTHER", "VALARIE MOLAISON", "JOSEPH DEVANEY", "MARY LACEY REUTHER", "VALARIE MOLAISON", "JOSEPH DEVANEY", "MARY LACEY REUTHER", "VALARIE MOLAISON", "JOSEPH DEVANEY" ]
[ 54800, 68274, 68416, 54800, 68274, 68416, 54800, 68274, 68416, 54800, 68274, 68416 ]
[ null, null, null, null, null, null, null, null, null, null, null, null ]
[ false, false, true, false, false, true, false, false, true, false, false, true ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/6594c5fa-12c5-4c78-b38b-6ac23ab82ec1/print/
6594c5fa-12c5-4c78-b38b-6ac23ab82ec1
6594c5fa-12c5-4c78-b38b-6ac23ab82ec1_40032268_188248
astellas pharma us, inc.
2018-07-20T20:40:21
YNCHF
2018-10-10T00:00:00
astellas pharma us
Pharmaceutical company
40,000
lobbying_income
service_provided
[ "Issues related to pharmaceutical pricing and NIH March In Rights", "Issues related to Medicare Part B and Medicare Part D" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2018-Q3
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)", "JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)", "JEFFREY J KIMBELL", "JODIE LOCKHART", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)", "JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)" ]
[ 42442, 51434, 60159, 53650, 42442, 51434, 60159, 53650 ]
[ null, null, "Legislative Director, Rep. Marsha Blackburn", "Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President", null, null, "Legislative Director, Rep. Marsha Blackburn", "Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President" ]
[ false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/9e88d2f6-88a3-4b01-afbf-acecee7e21b7/print/
9e88d2f6-88a3-4b01-afbf-acecee7e21b7
9e88d2f6-88a3-4b01-afbf-acecee7e21b7_46038_153900
astellas pharma us
2018-10-10T16:20:39
YNCHF
2018-10-12T00:00:00
astellas pharma us, inc.
Pharmaceuticals
50,000
lobbying_income
service_provided
[ "Issues related to P.L. 96-517, the Bayh-Dole Act; issues related to drug pricing; issues related to Medicare Part D Coverage; HR 6505 Medicare Negotiation and Compulsory Act; HR 6294 REVAMP Act; Conference report to HR 6157.", "S. 2482, Foreign Agents Registration Amendments Act of 2018; S.2039, Disclosing Foreign Influence Act; H.R. 4170, Disclosing Foreign Influence Act." ]
[ "HCR - Health Issues", "GOV - Government Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2018-Q3
2014-11-01
null
IL
US
1,004,265
0
null
2024-01-30T13:11:27.932595-05:00
PORTERFIELD, FETTIG & SEARS, LLC
400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US
305,054
government affairs
DAWN SEARS
38,091
+1 202-715-0845
[ "JEREMY RABINOVITZ", "JEREMY RABINOVITZ" ]
[ 61187, 61187 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/181397/
https://lda.senate.gov/api/v1/registrants/305054/
https://lda.senate.gov/filings/public/filing/85550049-8591-49b4-85e4-ad813ef5fd25/print/
85550049-8591-49b4-85e4-ad813ef5fd25
85550049-8591-49b4-85e4-ad813ef5fd25_305054_181397
astellas pharma us, inc.
2018-10-12T18:39:26
YNCHF
2018-10-22T00:00:00
astellas pharma us, inc.
null
560,000
a
service_provided
[ "House and Senate Appropriations for Fiscal Year ending Sept 30. 2018.", "Value of Prescription Drugs, Senate & House; Issues related to march-in rights under Bayh-Dole Act (Pub. L. 96-517); PAHPA (S. 2852/H.R. 6378) Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; REVAMP (H.R. 6294) Re-Valuing Anti-Microbial Products Act of 2018.", "Issues related to Medicare Part D policy (no specific bills).", "H.R. 4170 Disclosing Foreign Influence Act; S. 2482 Foreign Agents Registration Amendments Act; CLEAN Politics Act of 2018 (H.R. 6533/S. 3274)" ]
[ "BUD - Budget/Appropriations", "HCR - Health Issues", "MMM - Medicare/Medicaid", "LAW - Law Enforcement/Crime/Criminal Justice" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2018-Q3
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MARY LACEY REUTHER", "VALARIE MOLAISON", "JOSEPH DEVANEY", "MARY LACEY REUTHER", "VALARIE MOLAISON", "JOSEPH DEVANEY", "MARY LACEY REUTHER", "VALARIE MOLAISON", "JOSEPH DEVANEY", "MARY LACEY REUTHER", "VALARIE MOLAISON", "JOSEPH DEVANEY" ]
[ 54800, 68274, 68416, 54800, 68274, 68416, 54800, 68274, 68416, 54800, 68274, 68416 ]
[ null, null, null, null, null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/bd373f2f-d5ec-4906-b499-b367e6aaa532/print/
bd373f2f-d5ec-4906-b499-b367e6aaa532
bd373f2f-d5ec-4906-b499-b367e6aaa532_40032268_188248
astellas pharma us, inc.
2018-10-22T18:05:29
YNCHF
2018-10-22T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "S. 2482 - Foreign Agents Registration Amendment Act of 2018; S. 2039 - Disclosing Foreign Influence Act; HR 4170 - Disclosing Foreign Influence Act", "Issues relating to drug pricing, march-in rights under Bayh-Dole Act P.L. 96-517 and transparency. Issues related to the Medicare Part D coverage gap" ]
[ "FOR - Foreign Relations", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2018-Q3
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SEAN RICHARDSON", "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SEAN RICHARDSON" ]
[ 47178, 26450, 6542, 47178, 26450, 6542 ]
[ null, null, null, null, null, null ]
[ false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/d0159c91-5999-4256-9031-aea95ba722e2/print/
d0159c91-5999-4256-9031-aea95ba722e2
d0159c91-5999-4256-9031-aea95ba722e2_20744_127151
astellas pharma us, inc.
2018-10-22T19:43:18
YNCHF
2018-10-22T00:00:00
astellas pharma us, inc.
pharmaceutical company
50,000
lobbying_income
service_provided
[ "\"Issues related to lobbying disclosure for US affiliates in the Disclosing Foreign Influence Act (H.R.4170/S. 2039) and Foreign Agents Registration Amendments Act (S. 2482)\"", "Issues related to Medicare Part D", "HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. \nIssues related to the Bayh-Dole Act (Pub. L. 96-517)\nIssues related to drug pricing and value, generally\nPandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPA) (S. 2852/H.R. 6378) \nIssues related to the importation of prescription medicines, generally" ]
[ "LAW - Law Enforcement/Crime/Criminal Justice", "MMM - Medicare/Medicaid", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2018-Q3
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "LYDIA STRUNK", "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "LYDIA STRUNK (Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner))", "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "LYDIA STRUNK (Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner))" ]
[ 56477, 64580, 66328, 64580, 56477, 66328, 64580, 56477, 66328 ]
[ null, null, null, null, null, "Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner)", null, null, "Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner)" ]
[ false, false, false, false, false, true, false, false, true ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/20cc90e5-8bf0-462b-85af-59e5ecc36296/print/
20cc90e5-8bf0-462b-85af-59e5ecc36296
20cc90e5-8bf0-462b-85af-59e5ecc36296_400762305_195037
astellas pharma us, inc.
2018-10-22T20:57:00
YNCHF
2019-01-09T00:00:00
astellas pharma us
Pharmaceutical company
40,000
lobbying_income
service_provided
[ "Issues related to pharmaceutical pricing and NIH March In Rights", "Issues related to Medicare Part B and Medicare Part D" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2018-Q4
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)", "JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)", "JEFFREY J KIMBELL", "JODIE LOCKHART", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)", "JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)" ]
[ 42442, 51434, 60159, 53650, 42442, 51434, 60159, 53650 ]
[ null, null, "Legislative Director, Rep. Marsha Blackburn", "Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President", null, null, "Legislative Director, Rep. Marsha Blackburn", "Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President" ]
[ false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/5f2a842a-4eab-490e-9388-5406a0ec1faa/print/
5f2a842a-4eab-490e-9388-5406a0ec1faa
5f2a842a-4eab-490e-9388-5406a0ec1faa_46038_153900
astellas pharma us
2019-01-09T22:07:19
YNCHF
2019-01-17T00:00:00
astellas pharma us, inc.
Pharmaceuticals
50,000
lobbying_income
service_provided
[ "Issues related to P.L. 96-517, the Bayh-Dole Act; issues related to drug pricing; issues related to Medicare Part D Coverage; HR 6505 Medicare Negotiation and Competitive Licensing Act", "S. 2482, Foreign Agents Registration Amendments Act of 2018; S.2039, Disclosing Foreign Influence Act; H.R. 4170, Disclosing Foreign Influence Act" ]
[ "HCR - Health Issues", "GOV - Government Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "139 - Natl Institutes of Health (NIH)", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "139 - Natl Institutes of Health (NIH)", "1 - SENATE" ]
2018-Q4
2014-11-01
null
IL
US
1,004,265
0
null
2024-01-30T13:11:27.932595-05:00
PORTERFIELD, FETTIG & SEARS, LLC
400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US
305,054
government affairs
DAWN SEARS
38,091
+1 202-715-0845
[ "JEREMY RABINOVITZ", "JEREMY RABINOVITZ" ]
[ 61187, 61187 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/181397/
https://lda.senate.gov/api/v1/registrants/305054/
https://lda.senate.gov/filings/public/filing/23352e57-97ca-40b4-bb79-984cb8b4abdf/print/
23352e57-97ca-40b4-bb79-984cb8b4abdf
23352e57-97ca-40b4-bb79-984cb8b4abdf_305054_181397
astellas pharma us, inc.
2019-01-17T18:14:01
YNCHF
2019-01-18T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
service_provided
[ "Issues relating to drug pricing, march-in rights under Bayh-Dole Act P.L. 96-517 and transparency. Issues related to the Medicare Part D coverage gap", "S. 2482 - Foreign Agents Registration Amendment Act of 2018; S. 2039 - Disclosing Foreign Influence Act; HR 4170 - Disclosing Foreign Influence Act" ]
[ "HCR - Health Issues", "FOR - Foreign Relations" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2018-Q4
2009-04-01
null
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SEAN RICHARDSON", "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SEAN RICHARDSON" ]
[ 47178, 26450, 6542, 47178, 26450, 6542 ]
[ null, null, null, null, null, null ]
[ false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/e36ab401-47c7-4539-9879-ef04f90431dd/print/
e36ab401-47c7-4539-9879-ef04f90431dd
e36ab401-47c7-4539-9879-ef04f90431dd_20744_127151
astellas pharma us, inc.
2019-01-18T19:47:09
YNCHF
2019-01-21T00:00:00
astellas pharma us, inc.
null
460,000
a
service_provided
[ "Issues related to Medicare Part D policy (no specific bills).", "Value of Prescription Drugs, Senate & House; Issues related to march-in rights under Bayh-Dole Act (Pub. L. 96-517); PAHPA (S. 2852/H.R. 6378) Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018; REVAMP (H.R. 6294) Re-Valuing Anti-Microbial Products Act of 2018.", "House and Senate Appropriations for Fiscal Year ending Sept 30. 2018.", "H.R. 4170 Disclosing Foreign Influence Act; S. 2482 Foreign Agents Registration Amendments Act; CLEAN Politics Act of 2018 (H.R. 6533/S. 3274)" ]
[ "MMM - Medicare/Medicaid", "HCR - Health Issues", "BUD - Budget/Appropriations", "LAW - Law Enforcement/Crime/Criminal Justice" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2018-Q4
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MARY LACEY REUTHER", "VALARIE MOLAISON", "JOSEPH DEVANEY", "MARY LACEY REUTHER", "VALARIE MOLAISON", "JOSEPH DEVANEY", "MARY LACEY REUTHER", "VALARIE MOLAISON", "JOSEPH DEVANEY", "MARY LACEY REUTHER", "VALARIE MOLAISON", "JOSEPH DEVANEY" ]
[ 54800, 68274, 68416, 54800, 68274, 68416, 54800, 68274, 68416, 54800, 68274, 68416 ]
[ null, null, null, null, null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/0a9d5ab3-b43b-4e6b-9039-f063d656eb86/print/
0a9d5ab3-b43b-4e6b-9039-f063d656eb86
0a9d5ab3-b43b-4e6b-9039-f063d656eb86_40032268_188248
astellas pharma us, inc.
2019-01-21T20:04:18
YNCHF
2019-01-22T00:00:00
astellas pharma us, inc.
pharmaceutical company
50,000
lobbying_income
service_provided
[ "HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. \nIssues related to the Bayh-Dole Act (Pub. L. 96-517)\nIssues related to drug pricing and value, generally\nPandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPA) (S. 2852/H.R. 6378) \nIssues related to the importation of prescription medicines, generally", "Issues related to Medicare Part D", "\"Issues related to lobbying disclosure for US affiliates in the Disclosing Foreign Influence Act (H.R.4170/S. 2039) and Foreign Agents Registration Amendments Act (S. 2482)\"" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid", "LAW - Law Enforcement/Crime/Criminal Justice" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2018-Q4
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "LYDIA STRUNK (Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner))", "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "LYDIA STRUNK (Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner))", "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "LYDIA STRUNK" ]
[ 64580, 56477, 66328, 64580, 56477, 66328, 56477, 64580, 66328 ]
[ null, null, "Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner)", null, null, "Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner)", null, null, null ]
[ false, false, true, false, false, true, false, false, false ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/3c703155-5941-4043-b969-1598781b7589/print/
3c703155-5941-4043-b969-1598781b7589
3c703155-5941-4043-b969-1598781b7589_400762305_195037
astellas pharma us, inc.
2019-01-22T20:52:43
YNCHF
2019-02-12T00:00:00
astellas pharma us, inc.
Client is a pharmaceutical company.
7,500
lobbying_income
modify_service
[ "Development of policies to advance the antimicrobial research and development environment" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2013-Q4
2013-09-16
null
IL
US
393
0
0
2024-01-31T11:02:48.049026-05:00
THE MCMANUS GROUP
610 10th St. NW, Suite 300, Washington, DC, 20001, US
286,096
Consulting
NATE GASPAR
36,969
+1 434-989-7548
[ "BARRETT THORNHILL", "JOHN MCMANUS" ]
[ 59333, 9573 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/176451/
https://lda.senate.gov/api/v1/registrants/286096/
https://lda.senate.gov/filings/public/filing/9d700112-c269-47fa-9d5d-f4cb4c734a82/print/
9d700112-c269-47fa-9d5d-f4cb4c734a82
9d700112-c269-47fa-9d5d-f4cb4c734a82_286096_176451
astellas pharma us, inc.
2019-02-12T17:08:10
YNCHF
2019-04-04T00:00:00
astellas pharma us
Pharmaceutical company
40,000
lobbying_income
service_provided
[ "Issues related to pharmaceutical pricing and NIH March In Rights" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2019-Q1
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)", "JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)" ]
[ 42442, 51434, 60159, 53650 ]
[ null, null, "Legislative Director, Rep. Marsha Blackburn", "Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President" ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/1d951110-e389-4c96-b5be-b5ff6029d37d/print/
1d951110-e389-4c96-b5be-b5ff6029d37d
1d951110-e389-4c96-b5be-b5ff6029d37d_46038_153900
astellas pharma us
2019-04-04T19:10:20
YNCHF
2019-04-18T00:00:00
astellas pharma us, inc.
Pharmaceuticals
50,000
lobbying_income
service_provided
[ "H.R. 1, For the People Act of 2019, provisions and amendments related to FARA registration and PACS for foreign-owned subsidiaries of US companies", "Issues related to P.L. 96-517, the Bayh-Dole Act; issues related to drug pricing; issues related to Medicare Part D Coverage; H.R. 1046, Medicare Negotiation and Competitive Licensing Act" ]
[ "GOV - Government Issues", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2019-Q1
2014-11-01
null
IL
US
1,004,265
0
null
2024-01-30T13:11:27.932595-05:00
PORTERFIELD, FETTIG & SEARS, LLC
400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US
305,054
government affairs
DAWN SEARS
38,091
+1 202-715-0845
[ "JEREMY RABINOVITZ", "JEREMY RABINOVITZ" ]
[ 61187, 61187 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/181397/
https://lda.senate.gov/api/v1/registrants/305054/
https://lda.senate.gov/filings/public/filing/d4d6b792-bd2c-44d4-9aa6-471e42829b6d/print/
d4d6b792-bd2c-44d4-9aa6-471e42829b6d
d4d6b792-bd2c-44d4-9aa6-471e42829b6d_305054_181397
astellas pharma us, inc.
2019-04-18T17:54:00
YNCHF
2019-04-22T00:00:00
astellas pharma us, inc.
null
540,000
a
service_provided
[ "Biopharmaceutical innovation and patent policy issues.", "H.R. 1 - For the People Act of 2019", "Value of Prescription Drugs, Senate & House; Issues related to march-in rights under Bayh-Dole Act (Pub. L. 96-517); PAHPA (S. 2852/H.R. 6378).", "Issues related to Medicare Part D policies, including non-interference and rebate policy issues. Drug costs and pricing policy issues. Transparency policy issues.", "House and Senate Appropriations for Fiscal Year ending Sept 30, 2019." ]
[ "CPT - Copyright/Patent/Trademark", "LAW - Law Enforcement/Crime/Criminal Justice", "HCR - Health Issues", "MMM - Medicare/Medicaid", "BUD - Budget/Appropriations" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2019-Q1
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MARY LACEY REUTHER", "VALARIE MOLAISON", "JOSEPH DEVANEY", "MARY LACEY REUTHER", "VALARIE MOLAISON", "JOSEPH DEVANEY", "MARY LACEY REUTHER", "VALARIE MOLAISON", "JOSEPH DEVANEY", "MARY LACEY REUTHER", "VALARIE MOLAISON", "JOSEPH DEVANEY", "MARY LACEY REUTHER", "VALARIE MOLAISON", "JOSEPH DEVANEY" ]
[ 54800, 68274, 68416, 54800, 68274, 68416, 54800, 68274, 68416, 54800, 68274, 68416, 54800, 68274, 68416 ]
[ null, null, null, null, null, null, null, null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/cfde7334-b08c-43f7-a909-1b556f2d0b52/print/
cfde7334-b08c-43f7-a909-1b556f2d0b52
cfde7334-b08c-43f7-a909-1b556f2d0b52_40032268_188248
astellas pharma us, inc.
2019-04-22T17:59:08
YNCHF
2019-04-22T00:00:00
astellas pharma us, inc.
Pharmacuetical company.
60,000
lobbying_income
terminate
[ "HR 1 - Title IV - Campaign Finance Transparency", "Issues relating to drug pricing, march-in rights under Bayh-Dole Act P.L. 96-517, and transparency. Issues related to the Medicare Part D pricing reform." ]
[ "FOR - Foreign Relations", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2019-Q1
2009-04-01
2019-03-31
DC
US
1,005,002
0
0
2024-01-02T11:27:52.004862-05:00
TIBER CREEK GROUP
750 9th Street NW, Suite 501, Washington, DC, 20001, US
20,744
Government Relations.
GRACE BAUM
31,587
+1 202-381-6896
[ "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SEAN RICHARDSON", "JOHN MICHAEL GONZALEZ", "JONATHON JONES", "SEAN RICHARDSON" ]
[ 47178, 26450, 6542, 47178, 26450, 6542 ]
[ null, null, null, null, null, null ]
[ false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/127151/
https://lda.senate.gov/api/v1/registrants/20744/
https://lda.senate.gov/filings/public/filing/bc213f95-4158-45bb-874c-9a3063096611/print/
bc213f95-4158-45bb-874c-9a3063096611
bc213f95-4158-45bb-874c-9a3063096611_20744_127151
astellas pharma us, inc.
2019-04-22T20:02:32
YNCHF
2019-04-22T00:00:00
astellas pharma us, inc.
pharmaceutical company
50,000
lobbying_income
service_provided
[ "HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs\nIssues related to march-in rights under the Bayh-Dole Act (Pub. L. 96-517)\nIssues related to drug pricing and value, generally\nPandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPA)\nIssues related to the importation of prescription medicines, generally", "Issues related to lobbying disclosure for US affiliates", "Issues related to Medicare Part D, generally", "House and Senate Appropriations for FY ending Sept. 30, 2019" ]
[ "HCR - Health Issues", "LAW - Law Enforcement/Crime/Criminal Justice", "MMM - Medicare/Medicaid", "BUD - Budget/Appropriations" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2019-Q1
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "LYDIA STRUNK (Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner))", "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "LYDIA STRUNK", "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "LYDIA STRUNK (Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner))", "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "LYDIA STRUNK" ]
[ 64580, 56477, 66328, 56477, 64580, 66328, 64580, 56477, 66328, 56477, 64580, 66328 ]
[ null, null, "Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner)", null, null, null, null, null, "Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner)", null, null, null ]
[ false, false, true, false, false, false, false, false, true, false, false, false ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/056f5c8d-53e7-4cba-85ff-7f2ea26bc2f4/print/
056f5c8d-53e7-4cba-85ff-7f2ea26bc2f4
056f5c8d-53e7-4cba-85ff-7f2ea26bc2f4_400762305_195037
astellas pharma us, inc.
2019-04-23T02:01:19
YNCHF
2019-05-22T00:00:00
astellas pharma us, inc.
Pharmaceutical product manufacturer
5,000
lobbying_income
retainer
[]
null
null
2019-Q1
2019-02-01
null
IL
US
1,002,855
0
null
2024-01-25T16:57:50.222685-05:00
NVG, LLC
1640 Rhode Island Ave. NW, Suite 700, Washington, DC, 20036, US
76,833
Government Relations Firm
KATE SCHUMACHER
35,960
+1 202-540-1070
null
null
null
null
https://lda.senate.gov/api/v1/clients/169120/
https://lda.senate.gov/api/v1/registrants/76833/
https://lda.senate.gov/filings/public/filing/30c8e70b-1f4e-4e0a-8375-4e74ada4379a/print/
30c8e70b-1f4e-4e0a-8375-4e74ada4379a
30c8e70b-1f4e-4e0a-8375-4e74ada4379a_76833_169120
astellas pharma us, inc.
2019-05-22T19:34:01
YNCHF
2019-07-12T00:00:00
astellas pharma us
Pharmaceutical company
40,000
lobbying_income
service_provided
[ "Issues related to pharmaceutical pricing and NIH March In Rights" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2019-Q2
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)", "KENNETH LEE HODGE" ]
[ 42442, 51434, 53650, 139878 ]
[ null, null, "Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President", null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/68e55d5a-918d-47cb-9c0a-ca553f3b4edf/print/
68e55d5a-918d-47cb-9c0a-ca553f3b4edf
68e55d5a-918d-47cb-9c0a-ca553f3b4edf_46038_153900
astellas pharma us
2019-07-12T17:01:19
YNCHF
2019-07-22T00:00:00
astellas pharma us, inc.
Pharmaceuticals
50,000
lobbying_income
service_provided
[ "General issues related to FARA registration for foreign-owned subsidiaries of US companies", "Issues related to P.L. 96-517, the Bayh-Dole Act; S.1416, the Affordable Prescriptions for Patients Act; issues related to drug pricing; issues related to Medicare Part D coverage; H.R. 1046, Medicare Negotiation and Competitive Licensing Act; Reauthorization of the Patient-Centered Outcomes Research Institute (PCORI)" ]
[ "GOV - Government Issues", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2019-Q2
2014-11-01
null
IL
US
1,004,265
0
null
2024-01-30T13:11:27.932595-05:00
PORTERFIELD, FETTIG & SEARS, LLC
400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US
305,054
government affairs
DAWN SEARS
38,091
+1 202-715-0845
[ "JEREMY RABINOVITZ", "JEREMY RABINOVITZ" ]
[ 61187, 61187 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/181397/
https://lda.senate.gov/api/v1/registrants/305054/
https://lda.senate.gov/filings/public/filing/fda29f0a-5b9d-4da0-b9f8-8d0202ced030/print/
fda29f0a-5b9d-4da0-b9f8-8d0202ced030
fda29f0a-5b9d-4da0-b9f8-8d0202ced030_305054_181397
astellas pharma us, inc.
2019-07-22T15:31:14
YNCHF
2019-07-22T00:00:00
astellas pharma us, inc.
Pharmaceutical product manufacturer
60,000
lobbying_income
service_provided
[ "Intellectual property, data exclusivity and patent eligibility, generally; \nCREATES Act of 2019 (S.340)/(H.R.965);\nPreserve Access to Affordable Generics and Biosimilars Act (S.64)/(H.R.2375); \nStop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act (S.1224)/(H.R.2374); \nPrescription Pricing for People Act of 2019 (S.1227)/(H.R.2376); \nAffordable Prescriptions for Patients Act of 2019 (S.1416)", "Issues related to drug innovation; value of prescription drugs; issues related to march in rights under the Bayh-Dole Act 96-517; issues related to Medicare Part D and non-interference; rebate rule; transparency; H.R. 1040; H.R. 2296; H.R. 2113." ]
[ "CPT - Copyright/Patent/Trademark", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2019-Q2
2019-02-01
null
IL
US
1,002,855
0
null
2024-01-25T16:57:50.222685-05:00
NVG, LLC
1640 Rhode Island Ave. NW, Suite 700, Washington, DC, 20036, US
76,833
Government Relations Firm
KATE SCHUMACHER
35,960
+1 202-540-1070
[ "ANDREA LARUE", "LISA GERMAN FOSTER", "IRENE BUENO", "EDEN SHIFERAW", "ANDREA LARUE" ]
[ 20565, 38865, 35167, 69878, 20565 ]
[ null, null, null, null, null ]
[ false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/169120/
https://lda.senate.gov/api/v1/registrants/76833/
https://lda.senate.gov/filings/public/filing/f7da1b64-6372-4317-870c-e5bfe3f9794d/print/
f7da1b64-6372-4317-870c-e5bfe3f9794d
f7da1b64-6372-4317-870c-e5bfe3f9794d_76833_169120
astellas pharma us, inc.
2019-07-22T16:37:35
YNCHF
2019-07-22T00:00:00
astellas pharma us, inc.
pharmaceutical company
50,000
lobbying_income
service_provided
[ "HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs\nIssues related to march-in rights under the Bayh-Dole Act (Pub. L. 96-517)\nIssues related to drug pricing and value, generally", "Issues related to Medicare Part D, including non-interference, rebate policy issues\nIssues related to drug pricing, value, and transparency, generally", "House and Senate Appropriations for FY ending Sept. 30, 2019", "Issues related to lobbying disclosure for US affiliates" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid", "BUD - Budget/Appropriations", "LAW - Law Enforcement/Crime/Criminal Justice" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2019-Q2
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "LYDIA STRUNK (Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner))", "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "LYDIA STRUNK (Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner))", "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "LYDIA STRUNK", "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "LYDIA STRUNK" ]
[ 64580, 56477, 66328, 64580, 56477, 66328, 56477, 64580, 66328, 56477, 64580, 66328 ]
[ null, null, "Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner)", null, null, "Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner)", null, null, null, null, null, null ]
[ false, false, true, false, false, true, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/6fcea9ab-b611-4483-aad2-ec481d326a54/print/
6fcea9ab-b611-4483-aad2-ec481d326a54
6fcea9ab-b611-4483-aad2-ec481d326a54_400762305_195037
astellas pharma us, inc.
2019-07-22T18:02:34
YNCHF
2019-07-22T00:00:00
astellas pharma us, inc.
null
340,000
a
service_provided
[ "Biopharmaceutical innovation and patent policy issues; Affordable Prescriptions for Patients Act of 2019 (S.1416).", "Value of Prescription Drugs, Senate & House; Issues related to march-in rights under Bayh-Dole Act (Pub. L. 96-517).", "Issues related to Medicare Part D policies, including non-interference and rebate policy issues. Drug costs and pricing policy issues. Transparency policy issues.", "House and Senate Appropriations for Fiscal Year ending Sept 30, 2019." ]
[ "CPT - Copyright/Patent/Trademark", "HCR - Health Issues", "MMM - Medicare/Medicaid", "BUD - Budget/Appropriations" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2019-Q2
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MARY LACEY REUTHER", "VALARIE MOLAISON", "JOSEPH DEVANEY", "MARY LACEY REUTHER", "VALARIE MOLAISON", "JOSEPH DEVANEY", "MARY LACEY REUTHER", "VALARIE MOLAISON", "JOSEPH DEVANEY", "MARY LACEY REUTHER", "VALARIE MOLAISON", "JOSEPH DEVANEY" ]
[ 54800, 68274, 68416, 54800, 68274, 68416, 54800, 68274, 68416, 54800, 68274, 68416 ]
[ null, null, null, null, null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/3301a4de-a644-46af-bcbd-2eb12679f1bb/print/
3301a4de-a644-46af-bcbd-2eb12679f1bb
3301a4de-a644-46af-bcbd-2eb12679f1bb_40032268_188248
astellas pharma us, inc.
2019-07-22T18:19:17
YNCHF
2019-10-18T00:00:00
astellas pharma us
Pharmaceutical company
40,000
lobbying_income
service_provided
[ "Issues related to pharmaceutical drugs" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2019-Q3
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)", "KENNETH LEE HODGE" ]
[ 42442, 51434, 53650, 139878 ]
[ null, null, "Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President", null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/592d4a72-154e-4772-ab0e-6cf630ac87cb/print/
592d4a72-154e-4772-ab0e-6cf630ac87cb
592d4a72-154e-4772-ab0e-6cf630ac87cb_46038_153900
astellas pharma us
2019-10-18T18:49:26
YNCHF
2019-10-21T00:00:00
astellas pharma us, inc.
Pharmaceuticals
50,000
lobbying_income
service_provided
[ "Issues related to P.L. 96-517, the Bayh-Dole Act; H.R. 1046, Medicare Negotiation and Competitive Licensing Act; S. 2387, PAID Act; H.R. 3877, Bipartisan Budget Act of 2019; H.R. 3, Lower Drug Costs Now Act; S. 2543, Prescription Drug Pricing Reduction Act." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2019-Q3
2014-11-01
null
IL
US
1,004,265
0
null
2024-01-30T13:11:27.932595-05:00
PORTERFIELD, FETTIG & SEARS, LLC
400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US
305,054
government affairs
DAWN SEARS
38,091
+1 202-715-0845
[ "JEREMY RABINOVITZ" ]
[ 61187 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/181397/
https://lda.senate.gov/api/v1/registrants/305054/
https://lda.senate.gov/filings/public/filing/2ff2d1ba-1e73-4e78-aa6f-5472fa4e6cfc/print/
2ff2d1ba-1e73-4e78-aa6f-5472fa4e6cfc
2ff2d1ba-1e73-4e78-aa6f-5472fa4e6cfc_305054_181397
astellas pharma us, inc.
2019-10-21T18:40:01
YNCHF
2019-10-21T00:00:00
astellas pharma us, inc.
Pharmaceutical product manufacturer
60,000
lobbying_income
service_provided
[ "Intellectual property, data exclusivity and patent eligibility, generally; \nCREATES Act of 2019 (S.340)/(H.R.965);\nPreserve Access to Affordable Generics and Biosimilars Act (S.64)/(H.R.2375); \nStop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act (S.1224)/(H.R.2374); \nAffordable Prescriptions for Patients Act (S.1416); \nAffordable Prescriptions for Patients Through Improvements to Patent Litigation Act (H.R. 3199); \nAffordable Prescriptions for Patients Through Promoting Competition Act (H.R. 4398);\nProtecting Consumer Access to Generic Drugs Act (H.R. 1499).", "Issues related to drug innovation; value of prescription drugs; issues related to march in rights under the Bayh-Dole Act 96-517; issues related to Medicare Part D and non-interference; rebate rule; transparency; H.R. 2296; H.R. 2113; H.R. 3." ]
[ "CPT - Copyright/Patent/Trademark", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2019-Q3
2019-02-01
null
IL
US
1,002,855
0
null
2024-01-25T16:57:50.222685-05:00
NVG, LLC
1640 Rhode Island Ave. NW, Suite 700, Washington, DC, 20036, US
76,833
Government Relations Firm
KATE SCHUMACHER
35,960
+1 202-540-1070
[ "ANDREA LARUE", "LISA GERMAN FOSTER", "IRENE BUENO", "EDEN SHIFERAW", "ANDREA LARUE" ]
[ 20565, 38865, 35167, 69878, 20565 ]
[ null, null, null, null, null ]
[ false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/169120/
https://lda.senate.gov/api/v1/registrants/76833/
https://lda.senate.gov/filings/public/filing/290005fd-be40-456e-8a46-8b62d249804e/print/
290005fd-be40-456e-8a46-8b62d249804e
290005fd-be40-456e-8a46-8b62d249804e_76833_169120
astellas pharma us, inc.
2019-10-21T21:40:06
YNCHF
2019-10-21T00:00:00
astellas pharma us, inc.
pharmaceutical company
50,000
lobbying_income
service_provided
[ "HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs\nIssues related to march-in rights under the Bayh-Dole Act (Pub. L. 96-517)\nIssues related to drug pricing and value, generally", "Issues related to Medicare Part D, including non-interference, rebate policy issues\nIssues related to drug pricing, value, and transparency, generally", "Issues related to lobbying disclosure for US affiliates", "House and Senate Appropriations for FY ending Sept. 30, 2019" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid", "LAW - Law Enforcement/Crime/Criminal Justice", "BUD - Budget/Appropriations" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2019-Q3
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "LYDIA STRUNK (Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner))", "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "LYDIA STRUNK (Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner))", "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "LYDIA STRUNK", "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "LYDIA STRUNK" ]
[ 64580, 56477, 66328, 64580, 56477, 66328, 56477, 64580, 66328, 56477, 64580, 66328 ]
[ null, null, "Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner)", null, null, "Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner)", null, null, null, null, null, null ]
[ false, false, true, false, false, true, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/e8d42e44-80ac-4f2c-a5b8-edb2f5973b7c/print/
e8d42e44-80ac-4f2c-a5b8-edb2f5973b7c
e8d42e44-80ac-4f2c-a5b8-edb2f5973b7c_400762305_195037
astellas pharma us, inc.
2019-10-21T21:44:39
YNCHF
2019-10-21T00:00:00
astellas pharma us, inc.
null
410,000
a
service_provided
[ "House and Senate Appropriations for Fiscal Year ending Sept 30, 2019.", "Biopharmaceutical innovation and patent policy issues; Affordable Prescriptions for Patients Act of 2019 (S.1416).", "Value of Prescription Drugs, Senate & House; Issues related to march-in rights under Bayh-Dole Act (Pub. L. 96-517).", "Issues related to Medicare Part D policies, including non-interference and rebate policy issues. Drug costs and pricing policy issues. Transparency policy issues. H.R. 3 \"Lower Drug Costs Now Act of 2019.\"" ]
[ "BUD - Budget/Appropriations", "CPT - Copyright/Patent/Trademark", "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2019-Q3
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MARY LACEY REUTHER", "VALARIE MOLAISON", "JOSEPH DEVANEY", "MARY LACEY REUTHER", "VALARIE MOLAISON", "JOSEPH DEVANEY", "MARY LACEY REUTHER", "VALARIE MOLAISON", "JOSEPH DEVANEY", "MARY LACEY REUTHER", "VALARIE MOLAISON", "JOSEPH DEVANEY" ]
[ 54800, 68274, 68416, 54800, 68274, 68416, 54800, 68274, 68416, 54800, 68274, 68416 ]
[ null, null, null, null, null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/ea2b68c6-560a-41bd-9a28-bf27ed0313f9/print/
ea2b68c6-560a-41bd-9a28-bf27ed0313f9
ea2b68c6-560a-41bd-9a28-bf27ed0313f9_40032268_188248
astellas pharma us, inc.
2019-10-21T21:59:57
YNCHF
2019-10-24T00:00:00
astellas pharma us, inc.
Pharmaceutical manufacturer.
60,000
lobbying_income
service_provided
[ "Issues related to Medicare Part D and prescription drug pricing.", "Issues related to Medicare Part D and prescription drug pricing." ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2019-Q3
2019-07-01
null
IL
US
1,007,033
0
null
2024-01-30T13:15:28.215474-05:00
CAPITOL COUNSEL LLC
700 13th Street NW, 2nd Floor, Washington, DC, 20005, US
313,715
Government affairs.
TRACEY A. GRAY
39,384
+1 202-861-3200
[ "SHANNON FINLEY", "ANN JABLON", "SHANNON FINLEY", "ANN JABLON" ]
[ 45351, 65069, 45351, 65069 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/184651/
https://lda.senate.gov/api/v1/registrants/313715/
https://lda.senate.gov/filings/public/filing/ff3f5809-b8ec-410e-9a49-5ae15e780f92/print/
ff3f5809-b8ec-410e-9a49-5ae15e780f92
ff3f5809-b8ec-410e-9a49-5ae15e780f92_313715_184651
astellas pharma us, inc.
2019-10-24T14:07:50
YNCHF
2020-01-10T00:00:00
astellas pharma us, inc.
Pharmaceutical product manufacturer
60,000
lobbying_income
service_provided
[ "Issues related to drug innovation; value of prescription drugs; issues related to march in rights under the Bayh-Dole Act 96-517; issues related to Medicare Part D redesign and reform; H.R. 2296; H.R. 2113; H.R. 3; S. 2543; S. 1895.", "Intellectual property, data exclusivity and patent eligibility, generally; \nCREATES Act of 2019 (S.340)/(H.R.965);\nPreserve Access to Affordable Generics and Biosimilars Act (S.64)/(H.R.2375); \nStop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act (S.1224)/(H.R.2374); \nAffordable Prescriptions for Patients Act (S.1416); \nAffordable Prescriptions for Patients Through Improvements to Patent Litigation Act (H.R. 3199); \nAffordable Prescriptions for Patients Through Promoting Competition Act (H.R. 4398);\nProtecting Consumer Access to Generic Drugs Act (H.R. 1499)." ]
[ "HCR - Health Issues", "CPT - Copyright/Patent/Trademark" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2019-Q4
2019-02-01
null
IL
US
1,002,855
0
null
2024-01-25T16:57:50.222685-05:00
NVG, LLC
1640 Rhode Island Ave. NW, Suite 700, Washington, DC, 20036, US
76,833
Government Relations Firm
KATE SCHUMACHER
35,960
+1 202-540-1070
[ "LISA GERMAN FOSTER", "IRENE BUENO", "EDEN SHIFERAW", "ANDREA LARUE", "ANDREA LARUE" ]
[ 38865, 35167, 69878, 20565, 20565 ]
[ null, null, null, null, null ]
[ false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/169120/
https://lda.senate.gov/api/v1/registrants/76833/
https://lda.senate.gov/filings/public/filing/4278067f-7135-4404-b9e3-0366b3d9a2fa/print/
4278067f-7135-4404-b9e3-0366b3d9a2fa
4278067f-7135-4404-b9e3-0366b3d9a2fa_76833_169120
astellas pharma us, inc.
2020-01-10T20:10:27
YNCHF
2020-01-13T00:00:00
astellas pharma us, inc.
Pharmaceuticals
50,000
lobbying_income
service_provided
[ "Issues related to P.L. 96-517, the Bayh-Dole Act; H.R. 1046, Medicare Negotiation and Competitive Licensing Act; H.R. 3, Lower Drug Costs Now Act." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2019-Q4
2014-11-01
null
IL
US
1,004,265
0
null
2024-01-30T13:11:27.932595-05:00
PORTERFIELD, FETTIG & SEARS, LLC
400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US
305,054
government affairs
DAWN SEARS
38,091
+1 202-715-0845
[ "JEREMY RABINOVITZ" ]
[ 61187 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/181397/
https://lda.senate.gov/api/v1/registrants/305054/
https://lda.senate.gov/filings/public/filing/3942a761-290d-4896-b469-27446451c230/print/
3942a761-290d-4896-b469-27446451c230
3942a761-290d-4896-b469-27446451c230_305054_181397
astellas pharma us, inc.
2020-01-13T19:52:55
YNCHF
2020-01-19T00:00:00
astellas pharma us, inc.
Pharmaceutical manufacturer.
60,000
lobbying_income
service_provided
[ "Issues related to Medicare Part D and prescription drug pricing.", "Issues related to Medicare Part D and prescription drug pricing." ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2019-Q4
2019-07-01
null
IL
US
1,007,033
0
null
2024-01-30T13:15:28.215474-05:00
CAPITOL COUNSEL LLC
700 13th Street NW, 2nd Floor, Washington, DC, 20005, US
313,715
Government affairs.
TRACEY A. GRAY
39,384
+1 202-861-3200
[ "SHANNON FINLEY", "ANN JABLON", "SHANNON FINLEY", "ANN JABLON" ]
[ 45351, 65069, 45351, 65069 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/184651/
https://lda.senate.gov/api/v1/registrants/313715/
https://lda.senate.gov/filings/public/filing/c1965475-a0e3-4563-a7fe-a0e6432c5218/print/
c1965475-a0e3-4563-a7fe-a0e6432c5218
c1965475-a0e3-4563-a7fe-a0e6432c5218_313715_184651
astellas pharma us, inc.
2020-01-19T22:00:49
YNCHF
2020-01-21T00:00:00
astellas pharma us, inc.
pharmaceutical company
0
lobbying_income
service_provided
[ "Issues related to lobbying disclosure for US affiliates", "HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs\nIssues related to march-in rights under the Bayh-Dole Act (Pub. L. 96-517)\nIssues related to drug pricing and value, generally", "Issues related to Medicare Part D, including non-interference, rebate policy issues\nIssues related to drug pricing, value, and transparency, generally", "House and Senate Appropriations for FY ending Sept. 30, 2019" ]
[ "LAW - Law Enforcement/Crime/Criminal Justice", "HCR - Health Issues", "MMM - Medicare/Medicaid", "BUD - Budget/Appropriations" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2019-Q4
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "LYDIA STRUNK", "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "LYDIA STRUNK (Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner))", "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "LYDIA STRUNK (Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner))", "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "LYDIA STRUNK" ]
[ 56477, 64580, 66328, 64580, 56477, 66328, 64580, 56477, 66328, 56477, 64580, 66328 ]
[ null, null, null, null, null, "Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner)", null, null, "Deputy Floor Director Speaker Ryan (2015-17); Deputy Floor Director Speaker Boehner (2013-15); House Rules Committee 2011-13; House Republican Cloakroom Floor Assistant 2008-2011 (Minority Leader Boehner/Speaker Boehner)", null, null, null ]
[ false, false, false, false, false, true, false, false, true, false, false, false ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/ef7e0b2c-14ba-4e96-b11b-a79d26542c1b/print/
ef7e0b2c-14ba-4e96-b11b-a79d26542c1b
ef7e0b2c-14ba-4e96-b11b-a79d26542c1b_400762305_195037
astellas pharma us, inc.
2020-01-21T16:00:56
YNCHF
2020-01-21T00:00:00
astellas pharma us, inc.
null
670,000
a
service_provided
[ "Biopharmaceutical innovation and patent policy issues; Affordable Prescriptions for Patients Act of 2019 (S.1416).", "Value of Prescription Drugs, Senate & House; Issues related to Bayh-Dole Act (Pub. L. 96-517).", "Issues related to Medicare Part D policies, including non-interference and rebate policy issues. Drug costs and pricing policy issues. Transparency policy issues. H.R. 3 \"Lower Drug Costs Now Act of 2019.\" H.R.19 \"Lower Costs, More Cures Act of 2019.\"", "House and Senate Appropriations for Fiscal Year ending Sept 30, 2019." ]
[ "CPT - Copyright/Patent/Trademark", "HCR - Health Issues", "MMM - Medicare/Medicaid", "BUD - Budget/Appropriations" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2019-Q4
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MARY LACEY REUTHER", "VALARIE MOLAISON", "JOSEPH DEVANEY", "JOSEPH DEVANEY", "MARY LACEY REUTHER", "VALARIE MOLAISON", "MARY LACEY REUTHER", "VALARIE MOLAISON", "JOSEPH DEVANEY", "MARY LACEY REUTHER", "VALARIE MOLAISON", "JOSEPH DEVANEY" ]
[ 54800, 68274, 68416, 68416, 54800, 68274, 54800, 68274, 68416, 54800, 68274, 68416 ]
[ null, null, null, null, null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/420dbb8b-4942-486e-9f26-62a59b9010ec/print/
420dbb8b-4942-486e-9f26-62a59b9010ec
420dbb8b-4942-486e-9f26-62a59b9010ec_40032268_188248
astellas pharma us, inc.
2020-01-21T22:26:18
YNCHF
2020-01-22T00:00:00
astellas pharma us
Pharmaceutical company
40,000
lobbying_income
service_provided
[ "Issues related to pharmaceutical drugs" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2019-Q4
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)", "KENNETH LEE HODGE" ]
[ 42442, 51434, 53650, 139878 ]
[ null, null, "Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President", null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/fa176192-68c1-4f79-9ea0-d5752c61792e/print/
fa176192-68c1-4f79-9ea0-d5752c61792e
fa176192-68c1-4f79-9ea0-d5752c61792e_46038_153900
astellas pharma us
2020-01-22T03:47:44
YNCHF
2020-01-22T00:00:00
astellas pharma us, inc.
pharmaceutical company
50,000
lobbying_income
modify_service
[ "House and Senate Appropriations for FY ending Sept. 30, 2019", "HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs\nIssues related to march-in rights under the Bayh-Dole Act (Pub. L. 96-517)\nIssues related to drug pricing and value, generally", "Issues related to lobbying disclosure for US affiliates", "Issues related to Medicare Part D, including non-interference, rebate policy issues\nIssues related to drug pricing, value, and transparency, generally" ]
[ "BUD - Budget/Appropriations", "HCR - Health Issues", "LAW - Law Enforcement/Crime/Criminal Justice", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2019-Q4
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY" ]
[ 56477, 64580, 64580, 56477, 56477, 64580, 64580, 56477 ]
[ null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/47cb4cc6-4a4a-44f2-a8f3-295b3d544fed/print/
47cb4cc6-4a4a-44f2-a8f3-295b3d544fed
47cb4cc6-4a4a-44f2-a8f3-295b3d544fed_400762305_195037
astellas pharma us, inc.
2020-01-22T18:37:33
YNCHF
2020-04-16T00:00:00
astellas pharma us, inc.
Pharmaceuticals
50,000
lobbying_income
service_provided
[ "Issues related to P.L. 96-517, the Bayh-Dole Act; general issues pertaining to the cost of prescription drugs." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2020-Q1
2014-11-01
null
IL
US
1,004,265
0
null
2024-01-30T13:11:27.932595-05:00
PORTERFIELD, FETTIG & SEARS, LLC
400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US
305,054
government affairs
DAWN SEARS
38,091
+1 202-715-0845
[ "JEREMY RABINOVITZ" ]
[ 61187 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/181397/
https://lda.senate.gov/api/v1/registrants/305054/
https://lda.senate.gov/filings/public/filing/592021a2-7818-49fa-be8f-ef492196e3ea/print/
592021a2-7818-49fa-be8f-ef492196e3ea
592021a2-7818-49fa-be8f-ef492196e3ea_305054_181397
astellas pharma us, inc.
2020-04-16T14:15:48
YNCHF
2020-04-17T00:00:00
astellas pharma us, inc.
Pharmaceutical manufacturer.
60,000
lobbying_income
service_provided
[ "Issues related to Medicare Part D and prescription drug pricing; Coronavirus response efforts, including related provisions in: (1) H.R. 6074, the Coronavirus Preparedness and Response Supplemental Appropriations Act; (2) H.R. 6201, the Families First Coronavirus Response Act; and (3) H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act." ]
[ "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2020-Q1
2019-07-01
null
IL
US
1,007,033
0
null
2024-01-30T13:15:28.215474-05:00
CAPITOL COUNSEL LLC
700 13th Street NW, 2nd Floor, Washington, DC, 20005, US
313,715
Government affairs.
TRACEY A. GRAY
39,384
+1 202-861-3200
[ "SHANNON FINLEY", "ANN JABLON" ]
[ 45351, 65069 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/184651/
https://lda.senate.gov/api/v1/registrants/313715/
https://lda.senate.gov/filings/public/filing/8e5b18e3-df7b-4f4b-b3cf-dacfd497a141/print/
8e5b18e3-df7b-4f4b-b3cf-dacfd497a141
8e5b18e3-df7b-4f4b-b3cf-dacfd497a141_313715_184651
astellas pharma us, inc.
2020-04-17T21:50:02
YNCHF
2020-04-20T00:00:00
astellas pharma us
Pharmaceutical company
40,000
lobbying_income
service_provided
[ "Issues related to pharmaceutical drugs" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2020-Q1
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)", "JOHN R RAY (Legislative Assistant, Rep. Mike Kelly)", "DAVID RUDLOFF", "KENNETH LEE HODGE" ]
[ 42442, 51434, 53650, 60159, 67296, 68519, 139878 ]
[ null, null, "Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President", "Legislative Director, Rep. Marsha Blackburn", "Legislative Assistant, Rep. Mike Kelly", null, null ]
[ false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/79f27f41-42c2-4a95-91ae-0d11f7780d33/print/
79f27f41-42c2-4a95-91ae-0d11f7780d33
79f27f41-42c2-4a95-91ae-0d11f7780d33_46038_153900
astellas pharma us
2020-04-20T22:34:42
YNCHF
2020-04-20T00:00:00
astellas pharma us, inc.
pharmaceutical company
50,000
lobbying_income
service_provided
[ "Issues related to lobbying disclosure for US affiliates", "Issues related to Medicare Part D, including non-interference, rebate policy issues\nIssues related to drug pricing, value, and transparency, generally", "HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs\nIssues related to march-in rights under the Bayh-Dole Act (Pub. L. 96-517)\nIssues related to drug pricing and value, generally", "House and Senate Appropriations for FY ending Sept. 30, 2019" ]
[ "LAW - Law Enforcement/Crime/Criminal Justice", "MMM - Medicare/Medicaid", "HCR - Health Issues", "BUD - Budget/Appropriations" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2020-Q1
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR." ]
[ 56477, 64580, 64580, 56477, 64580, 56477, 56477, 64580 ]
[ null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/f1d0b8c2-2992-4c1a-ba74-d00231018f5c/print/
f1d0b8c2-2992-4c1a-ba74-d00231018f5c
f1d0b8c2-2992-4c1a-ba74-d00231018f5c_400762305_195037
astellas pharma us, inc.
2020-04-20T16:49:34
YNCHF
2020-04-20T00:00:00
astellas pharma us, inc.
Pharmaceutical product manufacturer
60,000
lobbying_income
service_provided
[ "Intellectual property, data exclusivity and patent eligibility, generally; \nCREATES Act of 2019 (S.340)/(H.R.965);\nPreserve Access to Affordable Generics and Biosimilars Act (S.64)/(H.R.2375); \nStop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act (S.1224)/(H.R.2374); \nAffordable Prescriptions for Patients Act (S.1416); \nAffordable Prescriptions for Patients Through Improvements to Patent Litigation Act (H.R. 3199); \nAffordable Prescriptions for Patients Through Promoting Competition Act (H.R. 4398);\nProtecting Consumer Access to Generic Drugs Act (H.R. 1499).", "Issues related to drug innovation; value of prescription drugs; issues related to march in rights under the Bayh-Dole Act 96-517; issues related to Medicare Part D redesign and reform; H.R. 2296; H.R. 2113; H.R. 3; S. 2543; S. 1895." ]
[ "CPT - Copyright/Patent/Trademark", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2020-Q1
2019-02-01
null
IL
US
1,002,855
0
null
2024-01-25T16:57:50.222685-05:00
NVG, LLC
1640 Rhode Island Ave. NW, Suite 700, Washington, DC, 20036, US
76,833
Government Relations Firm
KATE SCHUMACHER
35,960
+1 202-540-1070
[ "ANDREA LARUE", "LISA GERMAN FOSTER", "IRENE BUENO", "EDEN SHIFERAW" ]
[ 20565, 38865, 35167, 69878 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/169120/
https://lda.senate.gov/api/v1/registrants/76833/
https://lda.senate.gov/filings/public/filing/e8dac362-954f-49d1-917f-180c817eb9a7/print/
e8dac362-954f-49d1-917f-180c817eb9a7
e8dac362-954f-49d1-917f-180c817eb9a7_76833_169120
astellas pharma us, inc.
2020-04-20T20:17:09
YNCHF
2020-04-20T00:00:00
astellas pharma us, inc.
null
270,000
a
service_provided
[ "Biopharmaceutical innovation and patent policy issues; Affordable Prescriptions for Patients Act of 2019 (S.1416).", "Value of Prescription Drugs, Senate & House; Issues related to Bayh-Dole Act (Pub. L. 96-517).", "Issues related to Medicare Part D policies, including non-interference and rebate policy issues. Drug costs and pricing policy issues. Transparency policy issues. H.R. 3 \"Lower Drug Costs Now Act of 2019.\" H.R.19 \"Lower Costs, More Cures Act of 2019.\" S.2543 \"Prescription Drug Pricing Reduction Act.\" S. 3129 \"Lower Costs, More Cures.\"" ]
[ "CPT - Copyright/Patent/Trademark", "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2020-Q1
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MARY LACEY REUTHER", "VALARIE MOLAISON", "JOSEPH DEVANEY", "MARY LACEY REUTHER", "VALARIE MOLAISON", "JOSEPH DEVANEY", "MARY LACEY REUTHER", "VALARIE MOLAISON", "JOSEPH DEVANEY" ]
[ 54800, 68274, 68416, 54800, 68274, 68416, 54800, 68274, 68416 ]
[ null, null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/8588e876-621e-4dc7-a6b6-1d8bcb4390f5/print/
8588e876-621e-4dc7-a6b6-1d8bcb4390f5
8588e876-621e-4dc7-a6b6-1d8bcb4390f5_40032268_188248
astellas pharma us, inc.
2020-04-20T21:56:22
YNCHF
2020-07-17T00:00:00
astellas pharma us, inc.
null
510,000
a
service_provided
[ "Biopharmaceutical innovation and patent policy issues; Affordable Prescriptions for Patients Act of 2019 (S.1416).", "Value of Prescription Drugs, Senate & House; Issues related to Bayh-Dole Act (Pub. L. 96-517). Issues related to pharmaceutical supply chain, COVID-19 response and health appropriations (no specific bills). Health care issues related to the National Defense Authorization Act (H.R. 2500, S. 1790).", "Issues related to Medicare Part D policies, including non-interference and rebate policy issues. Drug costs and pricing policy issues. Transparency policy issues. H.R. 3 \"Lower Drug Costs Now Act of 2019.\" H.R.19 \"Lower Costs, More Cures Act of 2019.\" S.2543 \"Prescription Drug Pricing Reduction Act.\" S. 3129 \"Lower Costs, More Cures.\"" ]
[ "CPT - Copyright/Patent/Trademark", "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2020-Q2
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "MARY LACEY REUTHER", "VALARIE MOLAISON", "JOSEPH DEVANEY", "MARY LACEY REUTHER", "VALARIE MOLAISON", "JOSEPH DEVANEY", "MARY LACEY REUTHER", "VALARIE MOLAISON", "JOSEPH DEVANEY" ]
[ 54800, 68274, 68416, 54800, 68274, 68416, 54800, 68274, 68416 ]
[ null, null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/43964215-024c-4996-8d5b-dd892c32911f/print/
43964215-024c-4996-8d5b-dd892c32911f
43964215-024c-4996-8d5b-dd892c32911f_40032268_188248
astellas pharma us, inc.
2020-07-17T20:01:42
YNCHF
2020-07-17T00:00:00
astellas pharma us, inc.
Pharmaceuticals
50,000
lobbying_income
service_provided
[ "Issues related to P.L. 96-517, the Bayh-Dole Act; general issues pertaining to the cost of prescription drugs; general issues related to the pharmaceutical supply chain; general issues related to drug innovation; H.R. 1425, Patient Protection and Affordable Care Enhancement Act." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2020-Q2
2014-11-01
null
IL
US
1,004,265
0
null
2024-01-30T13:11:27.932595-05:00
PORTERFIELD, FETTIG & SEARS, LLC
400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US
305,054
government affairs
DAWN SEARS
38,091
+1 202-715-0845
[ "JEREMY RABINOVITZ" ]
[ 61187 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/181397/
https://lda.senate.gov/api/v1/registrants/305054/
https://lda.senate.gov/filings/public/filing/efa660cf-1617-4b2e-ab00-5361083bfa96/print/
efa660cf-1617-4b2e-ab00-5361083bfa96
efa660cf-1617-4b2e-ab00-5361083bfa96_305054_181397
astellas pharma us, inc.
2020-07-17T20:13:08
YNCHF
2020-07-20T00:00:00
astellas pharma us
Pharmaceutical company
40,000
lobbying_income
service_provided
[ "Issues related to pharmaceutical drugs" ]
[ "HCR - Health Issues" ]
[ "11 - Executive Office of the President (EOP)", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2020-Q2
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)", "JOHN R RAY (Legislative Assistant, Rep. Mike Kelly)", "DAVID RUDLOFF", "KENNETH LEE HODGE" ]
[ 42442, 51434, 53650, 60159, 67296, 68519, 139878 ]
[ null, null, "Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President", "Legislative Director, Rep. Marsha Blackburn", "Legislative Assistant, Rep. Mike Kelly", null, null ]
[ false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/49c94325-5617-4967-b023-268a7e15b9bd/print/
49c94325-5617-4967-b023-268a7e15b9bd
49c94325-5617-4967-b023-268a7e15b9bd_46038_153900
astellas pharma us
2020-07-20T22:33:26
YNCHF
2020-07-20T00:00:00
astellas pharma us, inc.
Pharmaceutical product manufacturer
60,000
lobbying_income
service_provided
[ "Issues related to drug innovation; value of prescription drugs; issues related to march in rights under the Bayh-Dole Act 96-517; issues related to Medicare Part D redesign and reform; H.R. 2296; H.R. 2113; H.R. 3; S. 2543; S. 1895.", "H.R. 6395 - National Defense Authorization Act for Fiscal Year 2021.", "Intellectual property, data exclusivity and patent eligibility, generally; \nCREATES Act of 2019 (S.340)/(H.R.965); \nPreserve Access to Affordable Generics and Biosimilars Act (S.64)/(H.R.2375); \nStop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act (S.1224)/(H.R.2374); \nAffordable Prescriptions for Patients Act (S.1416); \nAffordable Prescriptions for Patients Through Improvements to Patent Litigation Act (H.R. 3199); \nAffordable Prescriptions for Patients Through Promoting Competition Act (H.R. 4398); \nProtecting Consumer Access to Generic Drugs Act (H.R. 1499)." ]
[ "HCR - Health Issues", "DEF - Defense", "CPT - Copyright/Patent/Trademark" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2020-Q2
2019-02-01
null
IL
US
1,002,855
0
null
2024-01-25T16:57:50.222685-05:00
NVG, LLC
1640 Rhode Island Ave. NW, Suite 700, Washington, DC, 20036, US
76,833
Government Relations Firm
KATE SCHUMACHER
35,960
+1 202-540-1070
[ "LISA GERMAN FOSTER", "IRENE BUENO", "EDEN SHIFERAW", "IRENE BUENO", "LISA GERMAN FOSTER", "ANDREA LARUE" ]
[ 38865, 35167, 69878, 35167, 38865, 20565 ]
[ null, null, null, null, null, null ]
[ false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/169120/
https://lda.senate.gov/api/v1/registrants/76833/
https://lda.senate.gov/filings/public/filing/a3a1001b-c9d3-4c30-a4be-c549242e2547/print/
a3a1001b-c9d3-4c30-a4be-c549242e2547
a3a1001b-c9d3-4c30-a4be-c549242e2547_76833_169120
astellas pharma us, inc.
2020-07-20T19:42:57
YNCHF
2020-07-20T00:00:00
astellas pharma us, inc.
pharmaceutical company
50,000
lobbying_income
service_provided
[ "Issues related to Medicare Part D, including reforms, non-interference, rebate policy issues\nIssues related to drug pricing, value, and transparency, generally", "House and Senate Appropriations for FY 2021", "Issues related to lobbying disclosure for US affiliates", "HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs\nIssues related to march-in rights under the Bayh-Dole Act (Pub. L. 96-517)\nIssues related to drug pricing and value, generally" ]
[ "MMM - Medicare/Medicaid", "BUD - Budget/Appropriations", "LAW - Law Enforcement/Crime/Criminal Justice", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2020-Q2
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY" ]
[ 64580, 56477, 56477, 64580, 56477, 64580, 64580, 56477 ]
[ null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/cb34dccb-8aff-4aec-9973-6031b6765d5a/print/
cb34dccb-8aff-4aec-9973-6031b6765d5a
cb34dccb-8aff-4aec-9973-6031b6765d5a_400762305_195037
astellas pharma us, inc.
2020-07-20T21:56:46
YNCHF
2020-07-20T00:00:00
astellas pharma us, inc.
Pharmaceutical manufacturer.
50,000
lobbying_income
service_provided
[ "Issues related to Medicare Part D and prescription drug pricing; Coronavirus response efforts, including related provisions in: (1) H.R. 6074, the Coronavirus Preparedness and Response Supplemental Appropriations Act; (2) H.R. 6201, the Families First Coronavirus Response Act; and (3) H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act." ]
[ "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2020-Q2
2019-07-01
null
IL
US
1,007,033
0
null
2024-01-30T13:15:28.215474-05:00
CAPITOL COUNSEL LLC
700 13th Street NW, 2nd Floor, Washington, DC, 20005, US
313,715
Government affairs.
TRACEY A. GRAY
39,384
+1 202-861-3200
[ "SHANNON FINLEY", "ANN JABLON" ]
[ 45351, 65069 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/184651/
https://lda.senate.gov/api/v1/registrants/313715/
https://lda.senate.gov/filings/public/filing/5e35eaf4-ebb2-4869-89d4-5f4d9da949a3/print/
5e35eaf4-ebb2-4869-89d4-5f4d9da949a3
5e35eaf4-ebb2-4869-89d4-5f4d9da949a3_313715_184651
astellas pharma us, inc.
2020-07-21T00:27:18
YNCHF
2020-10-15T00:00:00
astellas pharma us, inc.
Pharmaceuticals
50,000
lobbying_income
service_provided
[ "Issues related to P.L. 96-517, the Bayh-Dole Act; general issues pertaining to the cost of prescription drugs; general issues related to the pharmaceutical supply chain; general issues related to drug innovation." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2020-Q3
2014-11-01
null
IL
US
1,004,265
0
null
2024-01-30T13:11:27.932595-05:00
PORTERFIELD, FETTIG & SEARS, LLC
400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US
305,054
government affairs
DAWN SEARS
38,091
+1 202-715-0845
[ "JEREMY RABINOVITZ" ]
[ 61187 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/181397/
https://lda.senate.gov/api/v1/registrants/305054/
https://lda.senate.gov/filings/public/filing/c4896666-17e9-4f61-9524-2d80a037f1b9/print/
c4896666-17e9-4f61-9524-2d80a037f1b9
c4896666-17e9-4f61-9524-2d80a037f1b9_305054_181397
astellas pharma us, inc.
2020-10-15T14:04:22
YNCHF
2020-10-15T00:00:00
astellas pharma us, inc.
Pharmaceutical manufacturer.
50,000
lobbying_income
service_provided
[ "Issues related to Medicare Part D and prescription drug pricing; Coronavirus response efforts, including related provisions in: (1) H.R. 6074, the Coronavirus Preparedness and Response Supplemental Appropriations Act; (2) H.R. 6201, the Families First Coronavirus Response Act; and (3) H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act." ]
[ "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2020-Q3
2019-07-01
null
IL
US
1,007,033
0
null
2024-01-30T13:15:28.215474-05:00
CAPITOL COUNSEL LLC
700 13th Street NW, 2nd Floor, Washington, DC, 20005, US
313,715
Government affairs.
TRACEY A. GRAY
39,384
+1 202-861-3200
[ "SHANNON FINLEY", "ANN JABLON" ]
[ 45351, 65069 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/184651/
https://lda.senate.gov/api/v1/registrants/313715/
https://lda.senate.gov/filings/public/filing/04c835bf-c458-4c3c-9a79-630dfe3177c9/print/
04c835bf-c458-4c3c-9a79-630dfe3177c9
04c835bf-c458-4c3c-9a79-630dfe3177c9_313715_184651
astellas pharma us, inc.
2020-10-16T01:34:33
YNCHF
2020-10-19T00:00:00
astellas pharma us, inc.
pharmaceutical company
50,000
lobbying_income
service_provided
[ "HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs\nIssues related to march-in rights under the Bayh-Dole Act (Pub. L. 96-517)\nIssues related to drug pricing and value, generally", "House and Senate Appropriations for FY 2021", "Issues related to Medicare Part D, including reforms, non-interference, rebate policy issues\nIssues related to drug pricing, value, and transparency, generally", "Issues related to lobbying disclosure for US affiliates" ]
[ "HCR - Health Issues", "BUD - Budget/Appropriations", "MMM - Medicare/Medicaid", "LAW - Law Enforcement/Crime/Criminal Justice" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2020-Q3
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR." ]
[ 64580, 56477, 56477, 64580, 64580, 56477, 56477, 64580 ]
[ null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/a7ce17ae-c7b9-4ac0-8e1a-27ae6aae11bb/print/
a7ce17ae-c7b9-4ac0-8e1a-27ae6aae11bb
a7ce17ae-c7b9-4ac0-8e1a-27ae6aae11bb_400762305_195037
astellas pharma us, inc.
2020-10-19T17:14:53
YNCHF
2020-10-19T00:00:00
astellas pharma us, inc.
Pharmaceutical product manufacturer
60,000
lobbying_income
service_provided
[ "Issues related to drug innovation; value of prescription drugs; issues related to march in rights under the Bayh-Dole Act 96-517; issues related to Medicare Part D redesign and reform; H.R. 2296; H.R. 2113; H.R. 3; S. 2543; S. 1895.", "H.R. 6395/S. 4049 - National Defense Authorization Act for Fiscal Year 2021." ]
[ "HCR - Health Issues", "DEF - Defense" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2020-Q3
2019-02-01
null
IL
US
1,002,855
0
null
2024-01-25T16:57:50.222685-05:00
NVG, LLC
1640 Rhode Island Ave. NW, Suite 700, Washington, DC, 20036, US
76,833
Government Relations Firm
KATE SCHUMACHER
35,960
+1 202-540-1070
[ "LISA GERMAN FOSTER", "IRENE BUENO", "EDEN SHIFERAW", "IRENE BUENO", "LISA GERMAN FOSTER" ]
[ 38865, 35167, 69878, 35167, 38865 ]
[ null, null, null, null, null ]
[ false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/169120/
https://lda.senate.gov/api/v1/registrants/76833/
https://lda.senate.gov/filings/public/filing/36269aa5-4506-42fa-9193-97ea19acfb21/print/
36269aa5-4506-42fa-9193-97ea19acfb21
36269aa5-4506-42fa-9193-97ea19acfb21_76833_169120
astellas pharma us, inc.
2020-10-19T20:15:58
YNCHF
2020-10-20T00:00:00
astellas pharma us
Pharmaceutical company
40,000
lobbying_income
service_provided
[ "Issues related to pharmaceutical drugs" ]
[ "HCR - Health Issues" ]
[ "11 - Executive Office of the President (EOP)", "34 - Health & Human Services, Dept of (HHS)", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2020-Q3
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)", "JOHN R RAY (Legislative Assistant, Rep. Mike Kelly)", "DAVID RUDLOFF", "KENNETH LEE HODGE" ]
[ 42442, 51434, 53650, 60159, 67296, 68519, 139878 ]
[ null, null, "Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President", "Legislative Director, Rep. Marsha Blackburn", "Legislative Assistant, Rep. Mike Kelly", null, null ]
[ false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/2df41571-4f1f-48b3-9074-9d35ce02a24b/print/
2df41571-4f1f-48b3-9074-9d35ce02a24b
2df41571-4f1f-48b3-9074-9d35ce02a24b_46038_153900
astellas pharma us
2020-10-21T00:26:15
YNCHF
2020-10-20T00:00:00
astellas pharma us, inc.
null
550,000
a
service_provided
[ "Biopharmaceutical innovation and patent policy issues; Affordable Prescriptions for Patients Act of 2019 (S.1416).", "Value of Prescription Drugs, Senate & House. Issues related to Bayh-Dole Act (Pub. L. 96-517). Issues related to pharmaceutical supply chain management, S.3537 Protecting Our Pharmaceutical Supply Chain. Health care issues related to the National Defense Authorization Act (H.R. 2500, S. 1790).", "Issues related to Medicare Part D policies, including patient access,non-interference and rebate policy issues. Drug costs and pricing policy issues. Transparency policy issues. H.R.3 Lower Drug Costs Now Act of 2019, H.R.19 Lower Costs, More Cures Act of 2019, S.2543 Prescription Drug Pricing Reduction Act, and S.3129 Lower Costs, More Cures." ]
[ "CPT - Copyright/Patent/Trademark", "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2020-Q3
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "VALARIE MOLAISON", "JOSEPH DEVANEY", "VALARIE MOLAISON", "JOSEPH DEVANEY", "VALARIE MOLAISON", "JOSEPH DEVANEY" ]
[ 68274, 68416, 68274, 68416, 68274, 68416 ]
[ null, null, null, null, null, null ]
[ false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/df954b7e-c346-45bc-a725-090336ff5bba/print/
df954b7e-c346-45bc-a725-090336ff5bba
df954b7e-c346-45bc-a725-090336ff5bba_40032268_188248
astellas pharma us, inc.
2020-10-20T15:00:11
YNCHF
2021-01-19T00:00:00
astellas pharma us, inc.
Pharmaceuticals
50,000
lobbying_income
service_provided
[ "General issues pertaining to the cost of prescription drugs; general issues related to drug research and innovation; Consolidated Appropriations Act of 2021, provision concerning Medicare Part B sequestration reimbursements." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2020-Q4
2014-11-01
null
IL
US
1,004,265
0
null
2024-01-30T13:11:27.932595-05:00
PORTERFIELD, FETTIG & SEARS, LLC
400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US
305,054
government affairs
DAWN SEARS
38,091
+1 202-715-0845
[ "JEREMY RABINOVITZ" ]
[ 61187 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/181397/
https://lda.senate.gov/api/v1/registrants/305054/
https://lda.senate.gov/filings/public/filing/e8110879-d602-454f-99ad-982adcadc973/print/
e8110879-d602-454f-99ad-982adcadc973
e8110879-d602-454f-99ad-982adcadc973_305054_181397
astellas pharma us, inc.
2021-01-19T22:09:54
YNCHF
2021-01-19T00:00:00
astellas pharma us, inc.
Pharmaceutical product manufacturer
0
lobbying_income
service_provided
[ "H.R. 6395/S. 4049 - National Defense Authorization Act for Fiscal Year 2021.", "Issues related to drug innovation; value of prescription drugs; issues related to march in rights under the Bayh-Dole Act 96-517; issues related to Medicare Part D redesign and reform; H.R. 2296; H.R. 2113; H.R. 3; S. 2543; S. 1895." ]
[ "DEF - Defense", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2020-Q4
2019-02-01
null
IL
US
1,002,855
0
null
2024-01-25T16:57:50.222685-05:00
NVG, LLC
1640 Rhode Island Ave. NW, Suite 700, Washington, DC, 20036, US
76,833
Government Relations Firm
KATE SCHUMACHER
35,960
+1 202-540-1070
[ "IRENE BUENO", "LISA GERMAN FOSTER", "LISA GERMAN FOSTER", "IRENE BUENO", "EDEN SHIFERAW" ]
[ 35167, 38865, 38865, 35167, 69878 ]
[ null, null, null, null, null ]
[ false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/169120/
https://lda.senate.gov/api/v1/registrants/76833/
https://lda.senate.gov/filings/public/filing/92901469-bc2b-4cd0-8ba1-05fc3d49c921/print/
92901469-bc2b-4cd0-8ba1-05fc3d49c921
92901469-bc2b-4cd0-8ba1-05fc3d49c921_76833_169120
astellas pharma us, inc.
2021-01-19T23:48:43
YNCHF
2021-01-20T00:00:00
astellas pharma us
Pharmaceutical company
40,000
lobbying_income
service_provided
[ "Issues related to pharmaceutical drugs" ]
[ "HCR - Health Issues" ]
[ "11 - Executive Office of the President (EOP)", "34 - Health & Human Services, Dept of (HHS)", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2020-Q4
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)", "JOHN R RAY (Legislative Assistant, Rep. Mike Kelly)", "DAVID RUDLOFF", "KENNETH LEE HODGE" ]
[ 42442, 51434, 53650, 60159, 67296, 68519, 139878 ]
[ null, null, "Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President", "Legislative Director, Rep. Marsha Blackburn", "Legislative Assistant, Rep. Mike Kelly", null, null ]
[ false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/03c9c2ae-03f2-4c95-867e-86374297e1d8/print/
03c9c2ae-03f2-4c95-867e-86374297e1d8
03c9c2ae-03f2-4c95-867e-86374297e1d8_46038_153900
astellas pharma us
2021-01-20T22:01:21
YNCHF
2021-01-20T00:00:00
astellas pharma us, inc.
pharmaceutical company
0
lobbying_income
service_provided
[ "Medicare prompt pay discount exclusion, including legislation to ensure appropriate reimbursement for drugs and biologics under Medicare Part B by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's Average Sales Price (ASP).\nASP, generally\nMedicare Part D, including removal of safe harbor protection for drug rebates\nMedicare Part B, including proposals to create an international pricing index and establish a competitive acquisition program\nPrescription Drug Pricing Reduction Act (S. 2543); inclusion of bona fide service fees in ASP calculation under Medicare Part B.\nS. 988 and H.R. 803; legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies.", "Issues related to lobbying disclosure for US affiliates", "House and Senate Appropriations for FY 2021" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid", "BUD - Budget/Appropriations" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2020-Q4
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR." ]
[ 64580, 56477, 64580, 56477, 56477, 64580 ]
[ null, null, null, null, null, null ]
[ false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/a0a4d4ce-ee1a-4119-8251-5194ef9b35db/print/
a0a4d4ce-ee1a-4119-8251-5194ef9b35db
a0a4d4ce-ee1a-4119-8251-5194ef9b35db_400762305_195037
astellas pharma us, inc.
2021-01-20T18:13:27
YNCHF
2021-01-20T00:00:00
astellas pharma us, inc.
pharmaceutical company
50,000
lobbying_income
modify_service
[ "Issues related to Medicare Part D, including reforms, non-interference, rebate policy issues\nIssues related to drug pricing, value, and transparency, generally", "House and Senate Appropriations for FY 2021", "Issues related to lobbying disclosure for US affiliates", "Issues related to march-in rights under the Bayh-Dole Act (Pub. L. 96-517)\nIssues related to drug pricing and value, generally" ]
[ "MMM - Medicare/Medicaid", "BUD - Budget/Appropriations", "LAW - Law Enforcement/Crime/Criminal Justice", "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2020-Q4
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY" ]
[ 64580, 56477, 56477, 64580, 56477, 64580, 64580, 56477 ]
[ null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/0abb3b37-58d8-4230-a397-28d6515c3db5/print/
0abb3b37-58d8-4230-a397-28d6515c3db5
0abb3b37-58d8-4230-a397-28d6515c3db5_400762305_195037
astellas pharma us, inc.
2021-01-20T18:23:05
YNCHF
2021-01-21T00:00:00
astellas pharma us, inc.
Pharmaceutical manufacturer.
50,000
lobbying_income
service_provided
[ "Issues related to Medicare Part D and prescription drug pricing; Coronavirus response efforts, including related provisions in: (1) H.R. 6074, the Coronavirus Preparedness and Response Supplemental Appropriations Act; (2) H.R. 6201, the Families First Coronavirus Response Act; and (3) H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act." ]
[ "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2020-Q4
2019-07-01
null
IL
US
1,007,033
0
null
2024-01-30T13:15:28.215474-05:00
CAPITOL COUNSEL LLC
700 13th Street NW, 2nd Floor, Washington, DC, 20005, US
313,715
Government affairs.
TRACEY A. GRAY
39,384
+1 202-861-3200
[ "SHANNON FINLEY", "ANN JABLON" ]
[ 45351, 65069 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/184651/
https://lda.senate.gov/api/v1/registrants/313715/
https://lda.senate.gov/filings/public/filing/ffe4a0f7-82a5-4c2c-a4c2-446fee9aa21b/print/
ffe4a0f7-82a5-4c2c-a4c2-446fee9aa21b
ffe4a0f7-82a5-4c2c-a4c2-446fee9aa21b_313715_184651
astellas pharma us, inc.
2021-01-21T00:56:14
YNCHF
2021-01-21T00:00:00
astellas pharma us, inc.
Pharmaceutical product manufacturer
60,000
lobbying_income
modify_service
[ "Issues related to drug innovation; value of prescription drugs; issues related to march in rights under the Bayh-Dole Act 96-517; issues related to Medicare Part D redesign and reform.", "H.R. 6395/S. 4049 - National Defense Authorization Act for Fiscal Year 2021." ]
[ "HCR - Health Issues", "DEF - Defense" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2020-Q4
2019-02-01
null
IL
US
1,002,855
0
null
2024-01-25T16:57:50.222685-05:00
NVG, LLC
1640 Rhode Island Ave. NW, Suite 700, Washington, DC, 20036, US
76,833
Government Relations Firm
KATE SCHUMACHER
35,960
+1 202-540-1070
[ "LISA GERMAN FOSTER", "IRENE BUENO", "EDEN SHIFERAW", "IRENE BUENO", "LISA GERMAN FOSTER" ]
[ 38865, 35167, 69878, 35167, 38865 ]
[ null, null, null, null, null ]
[ false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/169120/
https://lda.senate.gov/api/v1/registrants/76833/
https://lda.senate.gov/filings/public/filing/91693666-9825-48b5-a936-d0c46d49adef/print/
91693666-9825-48b5-a936-d0c46d49adef
91693666-9825-48b5-a936-d0c46d49adef_76833_169120
astellas pharma us, inc.
2021-01-21T23:25:24
YNCHF
2021-01-21T00:00:00
astellas pharma us, inc.
null
450,000
a
service_provided
[ "Biopharmaceutical innovation and patent policy issues; Affordable Prescriptions for Patients Act of 2019 (S.1416).", "Value of Prescription Drugs, Senate & House. Issues related to Bayh-Dole Act (Pub. L. 96-517). Issues related to pharmaceutical supply chain management, S.3537 Protecting Our Pharmaceutical Supply Chain. Health care issues related to the National Defense Authorization Act (Pub. L. 116-283).", "Issues related to Medicare Part D policies, including patient access, non-interference and rebate policy issues. Drug costs and pricing policy issues. Transparency policy issues. H.R.3 Lower Drug Costs Now Act of 2019, H.R.19 Lower Costs, More Cures Act of 2019, S.2543 Prescription Drug Pricing Reduction Act, and S.3129 Lower Costs, More Cures." ]
[ "CPT - Copyright/Patent/Trademark", "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2020-Q4
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "VALARIE MOLAISON", "VALARIE MOLAISON", "VALARIE MOLAISON" ]
[ 68274, 68274, 68274 ]
[ null, null, null ]
[ false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/128d4301-1f15-49be-98b1-1ac75301a3f0/print/
128d4301-1f15-49be-98b1-1ac75301a3f0
128d4301-1f15-49be-98b1-1ac75301a3f0_40032268_188248
astellas pharma us, inc.
2021-01-21T23:49:51
YNCHF
2021-04-19T00:00:00
astellas pharma us, inc.
Pharmaceuticals
50,000
lobbying_income
service_provided
[ "General issues pertaining to the cost of prescription drugs; general issues related to drug research and innovation. American Rescue Plan, provision pertaining to cap of Average Manufacturer Prices (AMP)." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2021-Q1
2014-11-01
null
IL
US
1,004,265
0
null
2024-01-30T13:11:27.932595-05:00
PORTERFIELD, FETTIG & SEARS, LLC
400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US
305,054
government affairs
DAWN SEARS
38,091
+1 202-715-0845
[ "JEREMY RABINOVITZ" ]
[ 61187 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/181397/
https://lda.senate.gov/api/v1/registrants/305054/
https://lda.senate.gov/filings/public/filing/35e05b54-254b-409e-b71d-181dc11fb2e6/print/
35e05b54-254b-409e-b71d-181dc11fb2e6
35e05b54-254b-409e-b71d-181dc11fb2e6_305054_181397
astellas pharma us, inc.
2021-04-19T18:06:46
YNCHF
2021-04-19T00:00:00
astellas pharma us, inc.
pharmaceutical company
60,000
lobbying_income
service_provided
[ "Issues related to march-in rights under the Bayh-Dole Act (Pub. L. 96-517)\nIssues related to drug pricing and value, generally\nIssues related to biopharmaceutical supply chain, generally", "Issues related to Medicare Part D, including reforms, non-interference, rebate policy issues\nIssues related to drug pricing, value, and transparency, generally" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2021-Q1
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY" ]
[ 64580, 56477, 64580, 56477 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/b591433f-1e53-4640-bd80-2aa405ba4cba/print/
b591433f-1e53-4640-bd80-2aa405ba4cba
b591433f-1e53-4640-bd80-2aa405ba4cba_400762305_195037
astellas pharma us, inc.
2021-04-19T20:00:41
YNCHF
2021-04-20T00:00:00
astellas pharma us
Pharmaceutical company
40,000
lobbying_income
service_provided
[ "Issues related to pharmaceutical drugs" ]
[ "HCR - Health Issues" ]
[ "11 - Executive Office of the President (EOP)", "34 - Health & Human Services, Dept of (HHS)", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2021-Q1
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)", "KENNETH LEE HODGE", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)", "JOHN R RAY (Legislative Assistant, Rep. Mike Kelly)", "DAVID RUDLOFF" ]
[ 42442, 51434, 53650, 139878, 60159, 67296, 68519 ]
[ null, null, "Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President", null, "Legislative Director, Rep. Marsha Blackburn", "Legislative Assistant, Rep. Mike Kelly", null ]
[ false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/aa3b5b2d-862e-4268-a130-2643b75496df/print/
aa3b5b2d-862e-4268-a130-2643b75496df
aa3b5b2d-862e-4268-a130-2643b75496df_46038_153900
astellas pharma us
2021-04-21T00:19:29
YNCHF
2021-04-20T00:00:00
astellas pharma us, inc.
Pharmaceutical manufacturer.
50,000
lobbying_income
service_provided
[ "Issues related to Medicare Part D and prescription drug pricing; Coronavirus response efforts, including related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2)." ]
[ "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2021-Q1
2019-07-01
null
IL
US
1,007,033
0
null
2024-01-30T13:15:28.215474-05:00
CAPITOL COUNSEL LLC
700 13th Street NW, 2nd Floor, Washington, DC, 20005, US
313,715
Government affairs.
TRACEY A. GRAY
39,384
+1 202-861-3200
[ "SHANNON FINLEY", "ANN JABLON" ]
[ 45351, 65069 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/184651/
https://lda.senate.gov/api/v1/registrants/313715/
https://lda.senate.gov/filings/public/filing/b5238faf-0253-4e6d-b91c-eb34abe3ae3b/print/
b5238faf-0253-4e6d-b91c-eb34abe3ae3b
b5238faf-0253-4e6d-b91c-eb34abe3ae3b_313715_184651
astellas pharma us, inc.
2021-04-20T19:34:00
YNCHF
2021-04-20T00:00:00
astellas pharma us, inc.
Pharmaceutical product manufacturer
60,000
lobbying_income
service_provided
[ "Issues related to drug innovation; value of prescription drugs;\nIssues related to march in rights under the Bayh-Dole Act 96-517; \nIssues related to Medicare Part D redesign and reform;\nIssues related to prostate cancer screening; \nRemoval of AMP Cap." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2021-Q1
2019-02-01
null
IL
US
1,002,855
0
null
2024-01-25T16:57:50.222685-05:00
NVG, LLC
1640 Rhode Island Ave. NW, Suite 700, Washington, DC, 20036, US
76,833
Government Relations Firm
KATE SCHUMACHER
35,960
+1 202-540-1070
[ "LISA GERMAN FOSTER", "IRENE BUENO", "EDEN SHIFERAW", "BRADY KING (Chief of Staff, Rep Kendra Horn; Chief of Staff, Sen Roland Burris; Chief of Staff, Rep Tim Mahoney; LD, Rep Allen Boyd; National Security Advisor, Sen Edward Kennedy; National Security Advisor, Sen Mark Dayton; Approps Associate, Rep Chet Edwards)" ]
[ 38865, 35167, 69878, 107387 ]
[ null, null, null, "Chief of Staff, Rep Kendra Horn; Chief of Staff, Sen Roland Burris; Chief of Staff, Rep Tim Mahoney; LD, Rep Allen Boyd; National Security Advisor, Sen Edward Kennedy; National Security Advisor, Sen Mark Dayton; Approps Associate, Rep Chet Edwards" ]
[ false, false, false, true ]
https://lda.senate.gov/api/v1/clients/169120/
https://lda.senate.gov/api/v1/registrants/76833/
https://lda.senate.gov/filings/public/filing/44569bd4-f2a1-4c91-be12-0af5f658226e/print/
44569bd4-f2a1-4c91-be12-0af5f658226e
44569bd4-f2a1-4c91-be12-0af5f658226e_76833_169120
astellas pharma us, inc.
2021-04-20T22:32:42
YNCHF
2021-04-20T00:00:00
astellas pharma us, inc.
null
450,000
a
service_provided
[ "Biopharmaceutical innovation and patent policy issues; Affordable Prescriptions for Patients Act of 2019 (S.1416).", "Value of Prescription Drugs, Senate & House. Issues related to Bayh-Dole Act (Pub.L.96-517). Issues related to pharmaceutical supply chain management, S.3537 Protecting Out Pharmaceutical Supply Chain. Health care issues related to the National Defense Authorization Act (Pub.L.116-283).", "Issues related to Medicare Part D policies, including patient access, non-interference and rebate policy issues. Drug costs and pricing issues. Transparency policy issues. H.R.3 Lower Drug Costs Now Act of 2019, H.R.19 Lower Costs, More Cures Act of 2019, S.2543 Prescription Drug Pricing Reduction Act, and S.3129 Lower Costs, More Cures.\nGeneral issue on the need for the Centers for Medicare & Medicaid Services to increase awareness around the need for screening and treatment for various cancers during the Covid-19 pandemic (no specific bills)." ]
[ "CPT - Copyright/Patent/Trademark", "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2021-Q1
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "VALARIE MOLAISON", "JONATHAN OEHMEN (Legislative Correspondent, Legislative Asst., and Sr. Legislative Asst. for Rep. John Sullivan (OK Dist. 1); Legislative Director and then Chief of Staff for Rep. Bill Flores (TX Dist. 17))", "VALARIE MOLAISON", "JONATHAN OEHMEN (Legislative Correspondent, Legislative Asst., and Sr. Legislative Asst. for Rep. John Sullivan (OK Dist. 1); Legislative Director and then Chief of Staff for Rep. Bill Flores (TX Dist. 17))", "VALARIE MOLAISON", "JAMES ROLLINS (None.)", "JONATHAN OEHMEN (Legislative Correspondent, Legislative Asst., and Sr. Legislative Asst. for Rep. John Sullivan (OK Dist. 1); Legislative Director and then Chief of Staff for Rep. Bill Flores (TX Dist. 17))" ]
[ 68274, 107392, 68274, 107392, 68274, 99438, 107392 ]
[ null, "Legislative Correspondent, Legislative Asst., and Sr. Legislative Asst. for Rep. John Sullivan (OK Dist. 1); Legislative Director and then Chief of Staff for Rep. Bill Flores (TX Dist. 17)", null, "Legislative Correspondent, Legislative Asst., and Sr. Legislative Asst. for Rep. John Sullivan (OK Dist. 1); Legislative Director and then Chief of Staff for Rep. Bill Flores (TX Dist. 17)", null, "None.", "Legislative Correspondent, Legislative Asst., and Sr. Legislative Asst. for Rep. John Sullivan (OK Dist. 1); Legislative Director and then Chief of Staff for Rep. Bill Flores (TX Dist. 17)" ]
[ false, true, false, true, false, true, true ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/b5dbd8b8-373d-48fd-90b0-4f19bac1aced/print/
b5dbd8b8-373d-48fd-90b0-4f19bac1aced
b5dbd8b8-373d-48fd-90b0-4f19bac1aced_40032268_188248
astellas pharma us, inc.
2021-04-21T01:42:40
YNCHF
2021-07-19T00:00:00
astellas pharma us, inc.
Pharmaceuticals
50,000
lobbying_income
service_provided
[ "General issues pertaining to the cost of prescription drugs; general issues related to drug research and innovation; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2021-Q2
2014-11-01
null
IL
US
1,004,265
0
null
2024-01-30T13:11:27.932595-05:00
PORTERFIELD, FETTIG & SEARS, LLC
400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US
305,054
government affairs
DAWN SEARS
38,091
+1 202-715-0845
[ "JEREMY RABINOVITZ" ]
[ 61187 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/181397/
https://lda.senate.gov/api/v1/registrants/305054/
https://lda.senate.gov/filings/public/filing/e840d959-48c0-4c50-a07d-6a5e4b9665ab/print/
e840d959-48c0-4c50-a07d-6a5e4b9665ab
e840d959-48c0-4c50-a07d-6a5e4b9665ab_305054_181397
astellas pharma us, inc.
2021-07-19T17:54:06
YNCHF
2021-07-19T00:00:00
astellas pharma us, inc.
Pharmaceutical product manufacturer
60,000
lobbying_income
service_provided
[ "Issues related to drug innovation; \nValue of prescription drugs;\nIssues related to march in rights under the Bayh-Dole Act 96-517; \nIssues related to prostate cancer screening; \nH.R. 3.", "Removal of AMP Cap;\nIssues related to Medicare Part D redesign and reform." ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2021-Q2
2019-02-01
null
IL
US
1,002,855
0
null
2024-01-25T16:57:50.222685-05:00
NVG, LLC
1640 Rhode Island Ave. NW, Suite 700, Washington, DC, 20036, US
76,833
Government Relations Firm
KATE SCHUMACHER
35,960
+1 202-540-1070
[ "LISA GERMAN FOSTER", "IRENE BUENO", "EDEN SHIFERAW", "BRADY KING", "LISA GERMAN FOSTER", "IRENE BUENO", "EDEN SHIFERAW", "BRADY KING" ]
[ 38865, 35167, 69878, 107387, 38865, 35167, 69878, 107387 ]
[ null, null, null, null, null, null, null, null ]
[ false, false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/169120/
https://lda.senate.gov/api/v1/registrants/76833/
https://lda.senate.gov/filings/public/filing/b86c0fa3-7cc0-4f00-92ec-b0817b596c93/print/
b86c0fa3-7cc0-4f00-92ec-b0817b596c93
b86c0fa3-7cc0-4f00-92ec-b0817b596c93_76833_169120
astellas pharma us, inc.
2021-07-19T20:05:53
YNCHF
2021-07-20T00:00:00
astellas pharma us, inc.
pharmaceutical company
60,000
lobbying_income
service_provided
[ "Issues related to march-in rights under the Bayh-Dole Act (Pub. L. 96-517)\nIssues related to drug pricing and value, generally\nIssues related to biopharmaceutical supply chain, generally", "Issues related to Medicare Part D, including reforms, non-interference, rebate policy issues\nIssues related to drug pricing, value, and transparency, generally" ]
[ "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2021-Q2
2012-01-01
null
IL
US
125
0
0
2024-04-22T11:03:08.110623-04:00
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
900 G Street NW, Suite 301, Washington, DC, 20001, US
400,762,305
Lobbying Firm
VINCENT ROBERTI
400,762,305
+1 202-846-8185
[ "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY", "VINCENT A. ROBERTI, SR.", "STEVEN E IRIZARRY" ]
[ 64580, 56477, 64580, 56477 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/195037/
https://lda.senate.gov/api/v1/registrants/400762305/
https://lda.senate.gov/filings/public/filing/55091067-507b-45d7-b10d-fb233809e796/print/
55091067-507b-45d7-b10d-fb233809e796
55091067-507b-45d7-b10d-fb233809e796_400762305_195037
astellas pharma us, inc.
2021-07-20T16:59:04
YNCHF
2021-07-20T00:00:00
astellas pharma us, inc.
Pharmaceutical manufacturer.
50,000
lobbying_income
service_provided
[ "Issues related to Medicare Part D and prescription drug pricing, including related provisions in H.R. 3, the Lower Drug Costs Now Act, and H.R. 19, the Lower Costs, More Cures Act.\n\nCoronavirus response efforts, including implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2)." ]
[ "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2021-Q2
2019-07-01
null
IL
US
1,007,033
0
null
2024-01-30T13:15:28.215474-05:00
CAPITOL COUNSEL LLC
700 13th Street NW, 2nd Floor, Washington, DC, 20005, US
313,715
Government affairs.
TRACEY A. GRAY
39,384
+1 202-861-3200
[ "SHANNON FINLEY", "ANN JABLON" ]
[ 45351, 65069 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/184651/
https://lda.senate.gov/api/v1/registrants/313715/
https://lda.senate.gov/filings/public/filing/538400e4-cef7-41a4-a170-440bf555fc71/print/
538400e4-cef7-41a4-a170-440bf555fc71
538400e4-cef7-41a4-a170-440bf555fc71_313715_184651
astellas pharma us, inc.
2021-07-20T18:33:37
YNCHF
2021-07-20T00:00:00
astellas pharma us, inc.
null
450,000
a
service_provided
[ "Biopharmaceutical innovation and patent policy issues; Affordable Prescriptions for Patients Act of 2019 (S.1416).", "Value of Prescription Drugs, Senate & House. Issues related to Bayh-Dole Act (Pub.L.96-517).", "Issues related to Medicare Part D policies, including patient access, non-interference and rebate policy issues. Drug costs and pricing issues. Transparency policy issues. H.R.3 Lower Drug Costs Now Act of 2019, H.R.19 Lower Costs, More Cures Act of 2019, S.2543 Prescription Drug Pricing Reduction Act, and S.3129 Lower Costs, More Cures.\nGeneral issue on the need for the Centers for Medicare & Medicaid Services to increase awareness around the need for screening and treatment for various cancers during the Covid-19 pandemic (no specific bills)." ]
[ "CPT - Copyright/Patent/Trademark", "HCR - Health Issues", "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE", "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2021-Q2
2018-05-17
null
IL
US
12
0
1
2024-01-24T11:02:27.018268-05:00
ASTELLAS PHARMA US, INC.
2375 Waterview Drive, Northbrook, IL, 60062, US
40,032,268
Pharmaceuticals
CHRISTINE BLOOMQUIST
39,903
+1 571-471-9064
[ "JONATHAN OEHMEN", "JONATHAN OEHMEN", "JAMES ROLLINS", "JONATHAN OEHMEN" ]
[ 107392, 107392, 99438, 107392 ]
[ null, null, null, null ]
[ false, false, false, false ]
https://lda.senate.gov/api/v1/clients/188248/
https://lda.senate.gov/api/v1/registrants/40032268/
https://lda.senate.gov/filings/public/filing/edda3861-3702-4442-b66a-8617215a3d91/print/
edda3861-3702-4442-b66a-8617215a3d91
edda3861-3702-4442-b66a-8617215a3d91_40032268_188248
astellas pharma us, inc.
2021-07-21T00:54:56
YNCHF
2021-07-22T00:00:00
astellas pharma us
Pharmaceutical company
40,000
lobbying_income
service_provided
[ "Issues related to pharmaceutical drugs" ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2021-Q2
2018-01-01
null
IL
US
583
0
null
2024-04-19T19:01:33.063682-04:00
JEFFREY J. KIMBELL AND ASSOCIATES
401 9th Street NW, Suite 920, Washington, DC, 20004, US
46,038
Consulting Firm
JEFFREY KIMBELL
34,381
+1 202-735-2590
[ "JEFFREY J KIMBELL", "JODIE LOCKHART", "KEITH STUDDARD (Legislative Director, Rep. Marsha Blackburn)", "JOHN R RAY (Legislative Assistant, Rep. Mike Kelly)", "DAVID RUDLOFF", "JOHN HERZOG (Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President)", "KENNETH LEE HODGE" ]
[ 42442, 51434, 60159, 67296, 68519, 53650, 139878 ]
[ null, null, "Legislative Director, Rep. Marsha Blackburn", "Legislative Assistant, Rep. Mike Kelly", null, "Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President", null ]
[ false, false, false, false, false, false, false ]
https://lda.senate.gov/api/v1/clients/153900/
https://lda.senate.gov/api/v1/registrants/46038/
https://lda.senate.gov/filings/public/filing/4d9a3f89-bef1-4d36-ba98-9887b13d2dff/print/
4d9a3f89-bef1-4d36-ba98-9887b13d2dff
4d9a3f89-bef1-4d36-ba98-9887b13d2dff_46038_153900
astellas pharma us
2021-07-22T17:13:21
YNCHF
2021-10-16T00:00:00
astellas pharma us, inc.
Pharmaceutical manufacturer.
50,000
lobbying_income
service_provided
[ "Issues related to Medicare Part D and prescription drug pricing, including related provisions in the Build Back Better Act, Budget Reconciliation Legislative Recommendations Relating to Drug Pricing, including provisions regarding Fair Drug Price Negotiation and Prescription Drug Inflation Rebates, in Subtitle E, Energy and Commerce, and Subtitle J, Ways and Means.\n\nCoronavirus response efforts, including implementation of related provisions in H.R. 1319, the American Rescue Plan Act (P.L. 117-2)." ]
[ "MMM - Medicare/Medicaid" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2021-Q3
2019-07-01
null
IL
US
1,007,033
0
null
2024-01-30T13:15:28.215474-05:00
CAPITOL COUNSEL LLC
700 13th Street NW, 2nd Floor, Washington, DC, 20005, US
313,715
Government affairs.
TRACEY A. GRAY
39,384
+1 202-861-3200
[ "SHANNON FINLEY", "ANN JABLON" ]
[ 45351, 65069 ]
[ null, null ]
[ false, false ]
https://lda.senate.gov/api/v1/clients/184651/
https://lda.senate.gov/api/v1/registrants/313715/
https://lda.senate.gov/filings/public/filing/224e27ce-5835-4469-b1e9-a4d78eef8537/print/
224e27ce-5835-4469-b1e9-a4d78eef8537
224e27ce-5835-4469-b1e9-a4d78eef8537_313715_184651
astellas pharma us, inc.
2021-10-16T19:19:40
YNCHF
2021-10-18T00:00:00
astellas pharma us, inc.
Pharmaceuticals
50,000
lobbying_income
service_provided
[ "H.R. 3684, Infrastructure, Investments and Jobs Act, healthcare provisions; H.R. 5376, Build Back Better Act, drug pricing provisions; H.R. 5237, Reduced Costs and Continued Cures Act; H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; general issues related to drug research and innovation." ]
[ "HCR - Health Issues" ]
[ "2 - HOUSE OF REPRESENTATIVES", "1 - SENATE" ]
2021-Q3
2014-11-01
null
IL
US
1,004,265
0
null
2024-01-30T13:11:27.932595-05:00
PORTERFIELD, FETTIG & SEARS, LLC
400 North Capitol Street, NW, Suite 363, Washington, DC, 20001, US
305,054
government affairs
DAWN SEARS
38,091
+1 202-715-0845
[ "JEREMY RABINOVITZ" ]
[ 61187 ]
[ null ]
[ false ]
https://lda.senate.gov/api/v1/clients/181397/
https://lda.senate.gov/api/v1/registrants/305054/
https://lda.senate.gov/filings/public/filing/634023b1-6031-4da3-928a-7bee27c17d5f/print/
634023b1-6031-4da3-928a-7bee27c17d5f
634023b1-6031-4da3-928a-7bee27c17d5f_305054_181397
astellas pharma us, inc.
2021-10-18T16:04:01